<SEC-DOCUMENT>0001178879-20-000004.txt : 20200109
<SEC-HEADER>0001178879-20-000004.hdr.sgml : 20200109
<ACCEPTANCE-DATETIME>20200109070342
ACCESSION NUMBER:		0001178879-20-000004
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200109
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200109
DATE AS OF CHANGE:		20200109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMICUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001178879
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				200422823
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33497
		FILM NUMBER:		20517015

	BUSINESS ADDRESS:	
		STREET 1:		1 CEDAR BROOK DRIVE
		CITY:			CRANBURY
		STATE:			NJ
		ZIP:			08512
		BUSINESS PHONE:		(609) 662-2000

	MAIL ADDRESS:	
		STREET 1:		1 CEDAR BROOK DRIVE
		CITY:			CRANBURY
		STATE:			NJ
		ZIP:			08512

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMICUS THERAPEUTICS INC
		DATE OF NAME CHANGE:	20020729
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k1820.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:2234A8CEFBE75BCDB81AFBA31F586C9C,x:c4112d527bbe4bd69fe1c8a0e463efb1-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:fold="http://www.amicustherapeutics.com/20200108" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q1F81920" name="dei:AmendmentFlag" id="Fact-39F0D1B9FA3656AB82ABEA2BB54AC77A-wk-Fact-39F0D1B9FA3656AB82ABEA2BB54AC77A" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q1F81920" name="dei:EntityCentralIndexKey" id="Fact-9D9CBBC7F8B5527895286921A980325E-wk-Fact-9D9CBBC7F8B5527895286921A980325E">0001178879</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q1F81920" name="dei:WrittenCommunications" id="Fact-DD7CC582EA82571ABEFD10A8483E1C47-wk-Fact-DD7CC582EA82571ABEFD10A8483E1C47" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="fold-20200108.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q1F81920">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001178879</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-09</xbrli:startDate>
			<xbrli:endDate>2020-01-09</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="sBBF8303A55985B459D4D9E3C06ED3362"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:232%;padding-bottom:0px;text-align:center;padding-left:37px;text-indent:24px;font-size:18pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;padding-left:36px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, D.C. 20549</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:18pt;"><span style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM </span><span><ix:nonNumeric id="d2561432e76-wk-Fact-70AF32C9AE8F591683EAABE3EAF4B39D" name="dei:DocumentType" contextRef="D2020Q1F81920"><span style="font-size:18pt;font-weight:bold;">8-K</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:left;padding-left:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT PURSUANT TO</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">SECTION 13 OR 15(d) OF THE</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;font-weight:bold;">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="line-height:120%;text-align:left;padding-left:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:16px;text-align:center;padding-left:34px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported): </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d2561432e97-wk-Fact-ED705A4B71145D6BA43E3DD1E8C921CF" name="dei:DocumentPeriodEndDate" contextRef="D2020Q1F81920" format="ixt:datemonthdayyearen">January 9, 2020</ix:nonNumeric></span></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:8px;text-align:center;padding-left:34px;text-indent:-2px;font-size:18pt;"><span><ix:nonNumeric id="d2561432e102-wk-Fact-C4C1D41D7FE95C1B96150FF29DE648C7" name="dei:EntityRegistrantName" contextRef="D2020Q1F81920"><span style="font-size:18pt;font-weight:bold;">AMICUS THERAPEUTICS, INC.</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:18pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="line-height:120%;text-align:center;padding-left:36px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;padding-left:36px;text-indent:-2px;font-size:10pt;"><span><ix:nonNumeric id="d2561432e114-wk-Fact-76AD74269FE2569685347FEB38645DFA" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q1F81920" format="ixt-sec:stateprovnameen"><span style="font-weight:bold;">Delaware</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction of</span></div><div style="line-height:120%;text-align:center;padding-left:34px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Incorporation)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:716px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:244px;"></td><td style="width:6px;"></td><td style="width:229px;"></td><td style="width:6px;"></td><td style="width:229px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Delaware</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e151-wk-Fact-92994F666DDE508EAA3D6A19365E3162" name="dei:EntityFileNumber" contextRef="D2020Q1F81920">001-33497</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d2561432e161-wk-Fact-3A088C8F63635F5EA41B8C5389F1141B" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q1F81920">71-0869350</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or Other Jurisdiction</span></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">of Incorporation)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission</span></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">File Number)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(I.R.S. Employer</span></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;text-indent:192px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e205-wk-Fact-B5C474C84B35575488B2D287E5C5D2F9" name="dei:EntityAddressAddressLine1" contextRef="D2020Q1F81920">1 Cedar Brook Drive</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e209-wk-Fact-F8066B6AAB9B584C9FCABDC4D7455F35" name="dei:EntityAddressCityOrTown" contextRef="D2020Q1F81920">Cranbury</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e213-wk-Fact-C9467773142950ACB7C5E5E3A3450C19" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q1F81920">NJ</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e217-wk-Fact-11B12A4FE62A5AF6952C9A440F189368" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q1F81920">08512</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices, and Zip Code)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e227-wk-Fact-FCD11A83243A550DBCAC5637EFEC22E5" name="dei:CityAreaCode" contextRef="D2020Q1F81920">609</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;">-</span><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e231-wk-Fact-2461D98A867F5701B747952166DFE458" name="dei:LocalPhoneNumber" contextRef="D2020Q1F81920">662-2000</ix:nonNumeric></span></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Registrant&#8217;s Telephone Number, Including Area Code</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;text-indent:192px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">(Former Name or Former Address, if Changed Since Last Report.)</span></div><div style="line-height:120%;text-align:left;padding-left:38px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:38px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:65px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:34px;"><span style="font-family:Arial Unicode MS;font-size:10pt;"> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:65px;text-indent:696px;font-size:10pt;"><span><ix:nonNumeric id="d2561432e263-wk-Fact-78CA76BCA0995796993478AC28B71F8B" name="dei:SolicitingMaterial" contextRef="D2020Q1F81920" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="line-height:120%;text-align:left;padding-left:65px;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d2561432e270-wk-Fact-3D1C11778A125FAF9B430C81BE22375F" name="dei:PreCommencementTenderOffer" contextRef="D2020Q1F81920" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="line-height:120%;text-align:left;padding-left:65px;text-indent:48px;font-size:10pt;"><span><ix:nonNumeric id="d2561432e277-wk-Fact-210DC4E11E0D505FBD1574CF98F50B92" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q1F81920" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:706px;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:233px;"></td><td style="width:204px;"></td><td style="width:269px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Title of each class</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e317-wk-Fact-219FFDE2D4F35DF5B58F0BD2D07F2D23" name="dei:Security12bTitle" contextRef="D2020Q1F81920">Common Stock Par Value $0.01</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e322-wk-Fact-52B21E5F456554168B36240C10137901" name="dei:TradingSymbol" contextRef="D2020Q1F81920">FOLD</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span><ix:nonNumeric id="d2561432e327-wk-Fact-920F42AADC6E5247A2D7476D699C18CF" name="dei:SecurityExchangeName" contextRef="D2020Q1F81920" format="ixt-sec:exchnameen">NASDAQ</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).  Emerging growth company </span><span><ix:nonNumeric id="d2561432e332-wk-Fact-F44E3590AD4C59CAB5710C333D01AC54" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q1F81920" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Arial Unicode MS;font-size:10pt;"><br/></span></div><div><a id="s14290099B3705F54BFC6A7E5B32EFEF4"></a></div><div style="line-height:232%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:232%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:232%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:38px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01 Other Events</span></div><div style="line-height:120%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:36px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On January 9, 2020, Amicus Therapeutics, Inc. issued a press release announcing preliminary 2019 revenue and Galafold (migalastat) commercial updates. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div><div style="line-height:120%;padding-left:36px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;padding-left:36px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:232%;padding-bottom:12px;text-align:left;padding-left:38px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01 Financial Statements and Exhibits</span></div><div style="line-height:174%;text-align:left;padding-left:38px;text-indent:-2px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(d) Exhibits:</span></div><div style="line-height:174%;text-align:left;padding-left:38px;text-indent:-2px;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:597px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:133px;"></td><td style="width:464px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit No.</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit99120.htm"><span style="font-family:inherit;font-size:10pt;">99.1</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit99120.htm"><span style="font-family:inherit;font-size:10pt;">January 8, 2020 Press Release</span></a></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><a id="s0728461D54AD5A6790B66C30E41569B0"></a></div><div style="line-height:232%;padding-bottom:0px;text-align:center;padding-left:37px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"> </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Signature Page</span></div><div style="line-height:232%;padding-bottom:0px;text-align:left;padding-left:37px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="line-height:174%;padding-bottom:0px;text-align:left;padding-left:37px;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:601px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:285px;"></td><td style="width:316px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">AMICUS THERAPEUTICS, INC.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Date: January 9, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;text-decoration:underline;">By:  /s/ Ellen S. Rosenberg</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Name: Ellen S. Rosenberg</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Title: Chief Legal Officer and Corporate Secretary</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99120.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sFFBFBE4D57C2E1DAA1D582FD4EC04106"></a></div><div><div style="line-height:130%;padding-bottom:10px;text-align:left;"><img src="exhibit991image1a23.jpg" alt="exhibit991image1a23.jpg" style="height:48px;width:142px;"></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:Arial;font-size:18pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:Arial;font-size:18pt;font-weight:bold;">Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">Galafold Revenue of $181 Million for Full-Year and $54 Million in Q4 Reflects Continued Strong Adoption &amp; Patient Adherence in All Key Global Regions</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">Galafold Marketing Authorizations Recently Received in Brazil, Colombia and Taiwan</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">Galafold on Track for $500M Revenue by 2023 with Potential for $1B Peak Revenue</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">Galafold Revenue Target for 2020 to be Announced at 38</font><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:Arial;font-size:11pt;font-style:italic;font-weight:bold;">&#32;Annual J.P. Morgan Healthcare Conference</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CRANBURY, NJ, Jan. 9, 2020</font><font style="font-family:Arial;font-size:10pt;">&#32;&#8211; Amicus Therapeutics (Nasdaq: FOLD), a global, patient dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases,</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:10pt;">today announced preliminary 2019 revenue and Galafold (migalastat) commercial updates. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics stated, &#8220;2019 represented another period of significant growth and adoption for Galafold across all geographies. We are pleased to announce our commercial performance surpassed our expectations for the year.  This reflects the strong continued adoption of this novel precision medicine for Fabry patients with amenable mutations as well as the 90%+ continued adherence and compliance rates seen with patients.  We are also pleased to have recently received notice of three new marketing authorizations in key countries that occurred late in the fourth quarter. These achievements highlight our company&#8217;s mission, which is focused on transforming the lives of people living with rare diseases, and for Galafold to ensure broad, worldwide access as soon as possible for all Fabry patients who may benefit.&#8221;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Fourth Quarter and Full Year 2019 Revenue </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Global revenue for Galafold in full-year 2019 was approximately $181 million (preliminary and unaudited) representing a year-over-year increase of 99% from total revenue of $91 million in 2018 and exceeded the Company&#8217;s updated 2019 guidance of $170 million to $180 million. Full-year revenue was negatively impacted by approximately $5 million in foreign currency headwinds. Fourth quarter Galafold revenue was approximately $54 million (preliminary and unaudited).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Marketing Authorizations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In 2019, Amicus made significant progress expanding access to Galafold around the globe, including most recently in Brazil, Colombia and Taiwan. Each of these countries granted approval for the first-in-class, oral small molecule precision medicine pharmacological chaperone Galafold (migalastat), as a monotherapy. Galafold is the first and only oral precision medicine for Fabry disease approved in these countries.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:10pt;">In Brazil, Amicus is working to complete the requirements to launch Galafold in the coming months. As part of the approval process for rare diseases in the country, patients will initially be required to go through a court injunction process, which will take approximately one year before receiving access to medication.</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:10pt;">Therefore, the Company expects more meaningful revenue contribution to begin in 2021 and beyond.   </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Galafold is approved in over 40 countries around the world, including the U.S., EU, Japan and others. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Amicus management will present a corporate overview and 2020 guidance at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14, 2020 at 8:30 a.m. PT. A Q&amp;A breakout session will immediately follow the presentation at 9:00 a.m. PT.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Live audio webcasts of the presentation and breakout session will be available and can be accessed through the Investors section of the Amicus Therapeutics corporate website at http://ir.amicusrx.com/, and will be archived for 90 days.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-weight:bold;text-decoration:underline;">About Galafold</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">Galafold</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"><sup style="vertical-align:top;line-height:120%;background-color:#ffffff; font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">&#160;(migalastat) 123 mg capsules is an oral pharmacological chaperone of alpha-Galactosidase A (alpha-Gal A) for the treatment of Fabry disease in adults who have amenable&#160;</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-style:italic;">GLA</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">&#160;variants. In these patients, Galafold works by stabilizing the body&#8217;s own dysfunctional enzyme so that it can clear the accumulation of disease substrate. Globally, Amicus </font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;"><img src="exhibit991image1a23.jpg" alt="exhibit991image1a23.jpg" style="height:48px;width:142px;"></div></div><div><br></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">Therapeutics estimates that approximately 35 to 50 percent of Fabry patients may have amenable&#160;</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-style:italic;">GLA</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">&#160;variants, though amenability rates within this range vary by geography. Galafold is approved in over 40 countries around the world, including the U.S., EU, Japan and others.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-weight:bold;">U. S. INDICATIONS AND USAGE</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">&#32;<br>Galafold is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-style:italic;">GLA</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">) variant based on&#160;</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-style:italic;">in&#160;vitro</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">&#160;assay data.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-weight:bold;">U.S. IMPORTANT SAFETY INFORMATION</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-weight:bold;">ADVERSE REACTIONS</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">&#32;<br>The most common adverse reactions reported with Galafold (&#8805;10%) were headache, nasopharyngitis, urinary tract infection, nausea and pyrexia.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-weight:bold;">USE IN SPECIFIC POPULATIONS</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">&#32;<br>There is insufficient clinical data on Galafold use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. Advise women of the potential risk to a fetus.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">It is not known if Galafold is present in human milk. Therefore, the developmental and health benefits of breastfeeding should be considered along with the mother&#8217;s clinical need for Galafold and any potential adverse effects on the breastfed child from Galafold or from the underlying maternal condition.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">Galafold is not recommended for use in patients with severe renal impairment or end-stage renal disease requiring dialysis.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The safety and effectiveness of Galafold have not been established in pediatric patients.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">To report Suspected Adverse Reactions, contact Amicus Therapeutics at 1-877-4AMICUS or FDA at&#160;1-800-FDA-1088 or&#160;www.fda.gov/medwatch</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;color:#333333;">.</font></div><div style="line-height:130%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">For additional information about Galafold, including the full U.S. Prescribing Information, please visit&#160;https://www.amicusrx.com/pi/Galafold.pdf</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;color:#333333;">.</font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:130%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">EU Important Safety Information</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Treatment with Galafold should be initiated and supervised by specialists experienced in the diagnosis and treatment of Fabry disease. Galafold is not recommended for use in patients with a nonamenable mutation.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Galafold is not intended for concomitant use with enzyme replacement therapy.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Galafold is not recommended for use in patients with Fabry disease who have severe renal impairment (&lt;30 mL/min/1.73 m</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">2</sup></font><font style="font-family:Arial;font-size:10pt;">). The safety and efficacy of Galafold in children 0&#8211;15 years of age have not yet been established. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">No dosage adjustments are required in patients with hepatic impairment or in the elderly population.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">There is very limited experience with the use of this medicine in pregnant women. If you are pregnant, think you may be pregnant, or are planning to have a baby, do not take this medicine until you have checked with your doctor, pharmacist, or nurse.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">While taking Galafold, effective birth control should be used. It is not known whether Galafold is excreted in human milk.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Contraindications to Galafold include hypersensitivity to the active substance or to any of the excipients listed in the PRESCRIBING INFORMATION.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">It is advised to periodically monitor renal function, echocardiographic parameters and biochemical markers (every 6 months) in patients initiated on Galafold or switched to Galafold.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">OVERDOSE: General medical care is recommended in the case of Galafold overdose.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The most common adverse reaction reported was headache, which was experienced by approximately 10% of patients who received Galafold. For a complete list of adverse reactions, please review the SUMMARY OF PRODUCT CHARACTERISTICS.</font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:130%;padding-bottom:10px;text-align:left;"><img src="exhibit991image1a23.jpg" alt="exhibit991image1a23.jpg" style="height:48px;width:142px;"></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">Call your doctor for medical advice about side effects. &#160;</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-weight:bold;">&#160;</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">For further important safety information for Galafold, including posology and method of administration, special warnings, drug interactions and adverse drug reactions, please see the European SmPC for Galafold available from the EMA website at www.ema.europa.eu.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">About Fabry Disease</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Fabry disease is an inherited lysosomal disorder caused by deficiency of an enzyme called alpha-galactosidase A (alpha-Gal A), which results from mutations in the GLA gene. The primary biological function of alpha-Gal A is to degrade specific lipids in lysosomes, including globotriaosylceramide (referred to here as GL-3 and also known as Gb3). Lipids that can be degraded by the action of alpha-Gal A are called "substrates" of the enzyme. Reduced or absent levels of alpha-Gal A activity lead to the accumulation of GL-3 in the affected tissues, including heart, kidneys, and skin. Accumulation of GL-3 and progressive deterioration of organ function is believed to lead to the morbidity and mortality of Fabry disease. The symptoms can be severe, differ from person to person, and begin at an early age.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;text-decoration:underline;">About&#160;Amicus Therapeutics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company&#8217;s website at www.amicusrx.com, and follow us on&#160;Twitter&#160;and&#160;LinkedIn.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">CONTACTS:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Investors:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">Andrew Faughnan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">Director, Investor Relations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;color:#0066ff;">afaughnan@amicusrx.com  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">(609) 662-3809</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Media:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christopher Byrne</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">Executive Director, Corporate Communications</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;color:#0066ff;">cbyrne@amicusrx.com </font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">(609) 662-2798</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">FOLD&#8211;G</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>fold-20200108.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.amicustherapeutics.com/20200108" xmlns:fold="http://www.amicustherapeutics.com/20200108" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200108_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200108_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200108_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200108_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CoverPage" roleURI="http://www.amicustherapeutics.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>fold-20200108_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:href="fold-20200108.xsd#CoverPage" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>fold-20200108_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:href="fold-20200108.xsd#CoverPage" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>fold-20200108_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CoverAbstract_4C427090B42E9AA8E4ECFB8B35FB5914_label_en-US" xlink:label="lab_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="lab_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_5BB88C907F9E1ED8D837FB8B35FB08CC_terseLabel_en-US" xlink:label="lab_dei_DocumentType_1D14796780E356E6A3D751B7620D0864" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_5BB88C907F9E1ED8D837FB8B35FB08CC_label_en-US" xlink:label="lab_dei_DocumentType_1D14796780E356E6A3D751B7620D0864" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_1D14796780E356E6A3D751B7620D0864" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_1D14796780E356E6A3D751B7620D0864" xlink:to="lab_dei_DocumentType_1D14796780E356E6A3D751B7620D0864" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_E2DF90494885C208E6BFFB8B35FB7E2F_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_869C02410EC75645B360D5BEDD670628" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_E2DF90494885C208E6BFFB8B35FB7E2F_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_869C02410EC75645B360D5BEDD670628" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_869C02410EC75645B360D5BEDD670628" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_869C02410EC75645B360D5BEDD670628" xlink:to="lab_dei_DocumentPeriodEndDate_869C02410EC75645B360D5BEDD670628" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_C9A78BB3F84A66307AA2FB8B35FFD04F_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_AE9976A6E022581F8F83BCBB52BDD00F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_C9A78BB3F84A66307AA2FB8B35FFD04F_label_en-US" xlink:label="lab_dei_EntityRegistrantName_AE9976A6E022581F8F83BCBB52BDD00F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_AE9976A6E022581F8F83BCBB52BDD00F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_AE9976A6E022581F8F83BCBB52BDD00F" xlink:to="lab_dei_EntityRegistrantName_AE9976A6E022581F8F83BCBB52BDD00F" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_FC70AF031603AF7AC9C5FB8B35FF61F2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_F545B97E32B75C79913F5573C5E45E71" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_FC70AF031603AF7AC9C5FB8B35FF61F2_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_F545B97E32B75C79913F5573C5E45E71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_F545B97E32B75C79913F5573C5E45E71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_F545B97E32B75C79913F5573C5E45E71" xlink:to="lab_dei_EntityIncorporationStateCountryCode_F545B97E32B75C79913F5573C5E45E71" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_3493F1314C92C234EFE3FB8B360040E8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_DCA3B38DD6285E9D9598A49993E9285F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_3493F1314C92C234EFE3FB8B360040E8_label_en-US" xlink:label="lab_dei_EntityFileNumber_DCA3B38DD6285E9D9598A49993E9285F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_DCA3B38DD6285E9D9598A49993E9285F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_DCA3B38DD6285E9D9598A49993E9285F" xlink:to="lab_dei_EntityFileNumber_DCA3B38DD6285E9D9598A49993E9285F" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_75F41C1B442F950F08ADFB8B36008604_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_D58F679808AF5811A558D0FAE4BC5252" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_75F41C1B442F950F08ADFB8B36008604_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_D58F679808AF5811A558D0FAE4BC5252" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_D58F679808AF5811A558D0FAE4BC5252" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_D58F679808AF5811A558D0FAE4BC5252" xlink:to="lab_dei_EntityTaxIdentificationNumber_D58F679808AF5811A558D0FAE4BC5252" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_DE8FDBE29AD24C2FD909FB8B360097D8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_7FCCE2995FD4549984C977482CF31256" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_DE8FDBE29AD24C2FD909FB8B360097D8_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_7FCCE2995FD4549984C977482CF31256" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_7FCCE2995FD4549984C977482CF31256" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_7FCCE2995FD4549984C977482CF31256" xlink:to="lab_dei_EntityAddressAddressLine1_7FCCE2995FD4549984C977482CF31256" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_12F5C937B3E05871D498FB8B36005910_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_14EE5358E7C456F89EB94ACD3DD03ACF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_12F5C937B3E05871D498FB8B36005910_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_14EE5358E7C456F89EB94ACD3DD03ACF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_14EE5358E7C456F89EB94ACD3DD03ACF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_14EE5358E7C456F89EB94ACD3DD03ACF" xlink:to="lab_dei_EntityAddressCityOrTown_14EE5358E7C456F89EB94ACD3DD03ACF" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_7454978A457461526264FB8B36006AFC_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_34A6DB203CC6572A8A95C4877DCC28AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7454978A457461526264FB8B36006AFC_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_34A6DB203CC6572A8A95C4877DCC28AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_34A6DB203CC6572A8A95C4877DCC28AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_34A6DB203CC6572A8A95C4877DCC28AA" xlink:to="lab_dei_EntityAddressStateOrProvince_34A6DB203CC6572A8A95C4877DCC28AA" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_07B48D93EEC148E3937BFB8B3600A5BC_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_35405C31B8585AB4B5FFD6DE0358F263" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_07B48D93EEC148E3937BFB8B3600A5BC_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_35405C31B8585AB4B5FFD6DE0358F263" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_35405C31B8585AB4B5FFD6DE0358F263" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_35405C31B8585AB4B5FFD6DE0358F263" xlink:to="lab_dei_EntityAddressPostalZipCode_35405C31B8585AB4B5FFD6DE0358F263" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_4030DB81F30F69D15866FB8B36004C15_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_99C93A6F622D587CB977900451C80B11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_4030DB81F30F69D15866FB8B36004C15_label_en-US" xlink:label="lab_dei_CityAreaCode_99C93A6F622D587CB977900451C80B11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_99C93A6F622D587CB977900451C80B11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_99C93A6F622D587CB977900451C80B11" xlink:to="lab_dei_CityAreaCode_99C93A6F622D587CB977900451C80B11" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_C45F05B64E4A3593A0AEFB8B36003A64_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_9D9995DA11435A2D9803541C86ECFCCF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_C45F05B64E4A3593A0AEFB8B36003A64_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_9D9995DA11435A2D9803541C86ECFCCF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_9D9995DA11435A2D9803541C86ECFCCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_9D9995DA11435A2D9803541C86ECFCCF" xlink:to="lab_dei_LocalPhoneNumber_9D9995DA11435A2D9803541C86ECFCCF" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_6E8387A29FE6966E9DBCFB8B3600122F_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_FC1DE3F6BF435D8787FE3B48968D7347" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_6E8387A29FE6966E9DBCFB8B3600122F_label_en-US" xlink:label="lab_dei_WrittenCommunications_FC1DE3F6BF435D8787FE3B48968D7347" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_FC1DE3F6BF435D8787FE3B48968D7347" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_FC1DE3F6BF435D8787FE3B48968D7347" xlink:to="lab_dei_WrittenCommunications_FC1DE3F6BF435D8787FE3B48968D7347" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_AF4F815BADECFF8CE801FB8B3600C77B_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_F1776D9A63105B489EEB709DC14EE4D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_AF4F815BADECFF8CE801FB8B3600C77B_label_en-US" xlink:label="lab_dei_SolicitingMaterial_F1776D9A63105B489EEB709DC14EE4D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_F1776D9A63105B489EEB709DC14EE4D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_F1776D9A63105B489EEB709DC14EE4D0" xlink:to="lab_dei_SolicitingMaterial_F1776D9A63105B489EEB709DC14EE4D0" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_4BE7EB10C2A7487C24ABFB8B3603247A_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_F8475D3F1F245A50B34C9C2F04901461" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_4BE7EB10C2A7487C24ABFB8B3603247A_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_F8475D3F1F245A50B34C9C2F04901461" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_F8475D3F1F245A50B34C9C2F04901461" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_F8475D3F1F245A50B34C9C2F04901461" xlink:to="lab_dei_PreCommencementTenderOffer_F8475D3F1F245A50B34C9C2F04901461" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_D217D792B97B2458D714FB8B36043C5A_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_765A14068541527E822F9012A3CE5056" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_D217D792B97B2458D714FB8B36043C5A_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_765A14068541527E822F9012A3CE5056" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_765A14068541527E822F9012A3CE5056" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_765A14068541527E822F9012A3CE5056" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_765A14068541527E822F9012A3CE5056" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_C34F8FFD5BDF7D3F0A99FB8B360427E3_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_2B14606A6B135120954E342397E940BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of each class</link:label>
    <link:label id="lab_dei_Security12bTitle_C34F8FFD5BDF7D3F0A99FB8B360427E3_label_en-US" xlink:label="lab_dei_Security12bTitle_2B14606A6B135120954E342397E940BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_2B14606A6B135120954E342397E940BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_2B14606A6B135120954E342397E940BE" xlink:to="lab_dei_Security12bTitle_2B14606A6B135120954E342397E940BE" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_B5FF41C1E5E8B42CC940FB8B3606FC16_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_7F15C9C58C8B59829495572AF6547888" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_B5FF41C1E5E8B42CC940FB8B3606FC16_label_en-US" xlink:label="lab_dei_TradingSymbol_7F15C9C58C8B59829495572AF6547888" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_7F15C9C58C8B59829495572AF6547888" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_7F15C9C58C8B59829495572AF6547888" xlink:to="lab_dei_TradingSymbol_7F15C9C58C8B59829495572AF6547888" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_3185F17F455395AA30E2FB8B3606F5E8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_846479F5A9495407ACBD25E277FB4F6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_3185F17F455395AA30E2FB8B3606F5E8_label_en-US" xlink:label="lab_dei_SecurityExchangeName_846479F5A9495407ACBD25E277FB4F6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_846479F5A9495407ACBD25E277FB4F6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_846479F5A9495407ACBD25E277FB4F6E" xlink:to="lab_dei_SecurityExchangeName_846479F5A9495407ACBD25E277FB4F6E" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4608D1397FE638427D35FB8B3606CA13_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_78C3822DD51C59749E870F0F91458200" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4608D1397FE638427D35FB8B3606CA13_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_78C3822DD51C59749E870F0F91458200" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_78C3822DD51C59749E870F0F91458200" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_78C3822DD51C59749E870F0F91458200" xlink:to="lab_dei_EntityEmergingGrowthCompany_78C3822DD51C59749E870F0F91458200" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_40DE1FEBA7B80A3FCF07FB8B36064353_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_EA8EE07D98345BBF8E697A46E9AD19B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_40DE1FEBA7B80A3FCF07FB8B36064353_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_EA8EE07D98345BBF8E697A46E9AD19B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_EA8EE07D98345BBF8E697A46E9AD19B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_EA8EE07D98345BBF8E697A46E9AD19B8" xlink:to="lab_dei_EntityCentralIndexKey_EA8EE07D98345BBF8E697A46E9AD19B8" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_C4F3C7D3F406D5343024FB8B360626C2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_6A18BE5CD19252C5B71B27385428AC99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_C4F3C7D3F406D5343024FB8B360626C2_label_en-US" xlink:label="lab_dei_AmendmentFlag_6A18BE5CD19252C5B71B27385428AC99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_6A18BE5CD19252C5B71B27385428AC99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_6A18BE5CD19252C5B71B27385428AC99" xlink:to="lab_dei_AmendmentFlag_6A18BE5CD19252C5B71B27385428AC99" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>fold-20200108_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:href="fold-20200108.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_1D14796780E356E6A3D751B7620D0864" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_DocumentType_1D14796780E356E6A3D751B7620D0864" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_869C02410EC75645B360D5BEDD670628" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_DocumentPeriodEndDate_869C02410EC75645B360D5BEDD670628" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_AE9976A6E022581F8F83BCBB52BDD00F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityRegistrantName_AE9976A6E022581F8F83BCBB52BDD00F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_F545B97E32B75C79913F5573C5E45E71" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityIncorporationStateCountryCode_F545B97E32B75C79913F5573C5E45E71" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_DCA3B38DD6285E9D9598A49993E9285F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityFileNumber_DCA3B38DD6285E9D9598A49993E9285F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_D58F679808AF5811A558D0FAE4BC5252" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityTaxIdentificationNumber_D58F679808AF5811A558D0FAE4BC5252" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_7FCCE2995FD4549984C977482CF31256" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityAddressAddressLine1_7FCCE2995FD4549984C977482CF31256" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_14EE5358E7C456F89EB94ACD3DD03ACF" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityAddressCityOrTown_14EE5358E7C456F89EB94ACD3DD03ACF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_34A6DB203CC6572A8A95C4877DCC28AA" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityAddressStateOrProvince_34A6DB203CC6572A8A95C4877DCC28AA" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_35405C31B8585AB4B5FFD6DE0358F263" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityAddressPostalZipCode_35405C31B8585AB4B5FFD6DE0358F263" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_99C93A6F622D587CB977900451C80B11" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_CityAreaCode_99C93A6F622D587CB977900451C80B11" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_9D9995DA11435A2D9803541C86ECFCCF" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_LocalPhoneNumber_9D9995DA11435A2D9803541C86ECFCCF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_FC1DE3F6BF435D8787FE3B48968D7347" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_WrittenCommunications_FC1DE3F6BF435D8787FE3B48968D7347" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_F1776D9A63105B489EEB709DC14EE4D0" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_SolicitingMaterial_F1776D9A63105B489EEB709DC14EE4D0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_F8475D3F1F245A50B34C9C2F04901461" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_PreCommencementTenderOffer_F8475D3F1F245A50B34C9C2F04901461" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_765A14068541527E822F9012A3CE5056" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_765A14068541527E822F9012A3CE5056" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_2B14606A6B135120954E342397E940BE" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_Security12bTitle_2B14606A6B135120954E342397E940BE" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_7F15C9C58C8B59829495572AF6547888" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_TradingSymbol_7F15C9C58C8B59829495572AF6547888" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_846479F5A9495407ACBD25E277FB4F6E" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_SecurityExchangeName_846479F5A9495407ACBD25E277FB4F6E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_78C3822DD51C59749E870F0F91458200" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityEmergingGrowthCompany_78C3822DD51C59749E870F0F91458200" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_EA8EE07D98345BBF8E697A46E9AD19B8" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_EntityCentralIndexKey_EA8EE07D98345BBF8E697A46E9AD19B8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_6A18BE5CD19252C5B71B27385428AC99" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_A8DD939ACD5C59718873EFCD9139F370" xlink:to="loc_dei_AmendmentFlag_6A18BE5CD19252C5B71B27385428AC99" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>exhibit991image1a23.jpg
<TEXT>
begin 644 exhibit991image1a23.jpg
M_]C_X  02D9)1@ ! 0$ 1P!'  #_VP!#  (" @(" @(" @(" @(" P0# @(#
M! 4$! 0$! 4&!04%!04%!@8'!P@'!P8)"0H*"0D,# P,# P,# P,# P,# S_
MVP!# 0,# P4$!0D&!@D-"PD+#0\.#@X.#P\,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" )@!Q,# 1$  A$! Q$!_\0
M'@ !  (# 0$! 0$           @)!@<*!00# @'_Q !J$  ! P," P,%!PL+
M$ 8)! ,  0(#! 4&!Q$($B$3,4$)%")1814C,D)2<8$6,SAB<G5VD:&SM!<9
M)#=#5E=T@I*5&#0U-E-C<X.%DY2QM=+3U"5$5%6BU29DA):CLL'"\46DP^'P
MI='_Q  < 0$  @(# 0              !@<$!0(#" '_Q !)$0$  0(# @@)
M" D$ @,! 0   0(#! 41!C$2(4%1<8&1L1,B,F%RH;+!T10S-4)2DN'P%B,T
M4V*"HL+2!Q5#<Q<D8^+Q)43_V@ , P$  A$#$0 _ +_
M
M
M
M
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M"HF9MW\\3'J]OTH:C$Y?B,-\[;JIZ8T;;#8_#XGYJY35T3JSHQ&6
M
M
M
M
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MQ$*TSC9O%9;XU4<*C[4;NOF[O.LC*-H\+F/BTSP:_LS[N?O\R4)'V_
M
M
M
M
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MRQ*O1K+G\MO]^[T_=-TW>E=;0;&Q.M[!QQ\M'^/P[.9860;83&EG%SQ<E?\
ME\>WG6Z4M535M-3UM%405='5QLFI*N%Z21RQR)S,>Q[=T<UR+NBH5I53-,Z3
MO6335%4:QN?N?'T
M
M
M
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MT,B<S)(WMW145%Z*5!<MU6ZIIJC286W;N4W*8JIG6)?><',
M
M
M
M                                                   !A6H&H6(Z
M78M<<RS>\066Q6U$22=^[GRR.^!##&W=TDC_  :U/;W(JF5@L%=QEV+5J-:I
M_.L^9BXS&VL':F[=G2F/SI'G4!\2G%%E_$%?%A?V]@T_MDRNQ_$6/W15;S(V
MJK%3I),K5^Y8G1OQG.N?(=GK65T<]R=]7NCS=ZG,]V@NYG7S6XW4^^?/W(N$
MA1\             !.7A%XNKEHG<H,+S2>JN>E=SGZIUDFLLTJ^E44[>JK$J
MKO+$GW;/2W1\1VFV9IS"GPMKBNQ_5YI\_-/5/FENS>TE67U>"N\=J?Z?/'FY
MXZX\]\%KNEMO=MH;Q9ZZEN=JN<#*FW7&F>DD,T,B<S)(WMW145%Z*4]<MU6Z
MIIJC286[;N4W*8JIG6)?><',
M
M
M
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M34E7"])(Y8Y$YF/8]NZ.:Y%W14*@JIFF=)WK<IJBJ-8W/W/CZ
M
M
M
M                                                 ,;R_+L>P/&K
MQE^5W*&T8_8J=:FY5\FZHUJ=$1K4W5SG*J-:U.JJJ(G4[\-AKF)N1;MQK5.Y
MT8G$V\-;FY<G2F-[GAXE>(W(^(/,/="I26U8;9'R18AC7-TBB<O6HGVZ.GE1
M$YE[D39J=$W6[LAR.WE=G2..N?*GW1YH4KGN=W,SNZSQ41Y,>^?/*-IO6C
M                !9YP.<6CL7JK?HSJ5=-\9KI$APC(JI_]CIG[(VBF>]>E
M.]?K:_$<NWP%]"O]KMF_#1.*L1XT>5'VO/'GY^?IWS[9/:/P,QA;\^+]6>;S
M3YN;FZ-US!5JSP
M
M
M
M            #Y*ZNHK715=RN5734%OH(7U%=75#VQPPPQMYGR2/=LC6M1-U
M53E11-<Q33&LRXUUQ1'"JXHA0%Q>\45=KOD_N#CE144NEV-3K[B4JHL;KC4-
MW:M?.U41>J+M$UWP6]>CG.+GV9V>C+;7#K^=JW^:/LQ[U.;2Y_.8W.!1\U3N
M\\_:GW(9DI1<                    !=?P+<4ZYY;*;1_4"Y]IFMDI]L2N
M]0[T[K0P-^L/<OPJB!J?.]B<R[N:Y5JC:_9WY-5\ILQXD^5'V9Y^B?5/4M39
M+:#Y33\FO3X\>3/VHYNF/7'6LE((G(
M
M
M
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MK+,1P?J3QTSYN;IC\5V[/YS3F6'X7UXXJH]_1/X)+FA;T
M
M
M
M                                        %>W'%Q0KI=89-,<'N'9Z
M@Y/3?]*W&!WIVBW2HJ<R*GP9YDZ,\6MW?T7D4FNR.S_RROY1=C]73N_BGX1R
M]G.AFUF?_(Z/ 6I_65;_ .&/C/)V\RC5555557=5[U+=5*_P
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MNG@Y.YR+U1=T7J4/B,/7A[E5NN-*J9TE>>'OT7[<7*)UIF-8>^=+N
M
M
M
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MGBJ\\<D]7+YNA/\ 8K.?!U_)+D\4\=/FGECK[^E<B5<LX
M
M
M
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M7HG?N4/GF5SEV*JM?5WT^>F=W9NGH7IDF9QF&%IN_6W5>:J/COZV]C3MN
M
M
M
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M2XKP57DW.+^;ZOPZU\Y3JWP
M
M              'DUE^L5OF;3U]ZM-#.Y[8VP5%1%&]7N3F:U&N<B[JG5$.R
MFS75QQ3,NNJ]13Q3,0]""H@JHFSTT\-1 _?DFB<CVKLNR[*G3O.$Q,<4N<3$
M[G['Q]
M
M$.>,SB&;HAIVZV6"L2/43-HY:/&^1R=I0P;;5%P5/#LT7EC]<BHO5&N)1LMD
MG^XXCA5Q^KHXY\_-3\?-THSM1G7^WX?@T3^LKXH\W/5\//T.?-[WR/=)(YSW
MO57/>Y=U55[U52ZE,/Y               SG3K3G+M5<KMN&83:I;K>KD_PW
M2&GB3X<]1)LJ1QL\7+\R;JJ(N)CL=:P5J;MV=(CU^:/.R\%@;N,NQ:M1K,^K
MSSYE_'#;PN8=P_61L\;8+_J!<H4;?\ND9U3F1JNIJ-%3>.%')]T_O=X-;3.>
M[0WLSKYK<;J??///=R+CR/9^SEE'/<G?5[H\W>E&1YOP     *"/*#VEMNXD
M;S6(UJ+?K):JYZIMU5D/FFZ[>RG\2YMBKG"RZ(YJJH]>OO4[MG;X.8S//3$^
MK3W(1$L10   /VIYYZ6>&JII9*>III&RT\\:\KV/8N[7-5.Y44^3$3&DOL3,
M3K#IDX>M48M8M(,,SE9(G72MHTI<CB8J>]W*D]YJMVIMR\[F]HU/DN:4'G>7
M_(,779Y->+T9XX^'2OC)<P^782B[RZ<?I1O^+=1JFT
M
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MM5317&DQOA9=J[3=IBJB=8GE>F<',
M
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MOC1TQQ3ZM.Q<*5BLP
M
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MZ)[^E=.54M(
M
M "FORAW$ M]O<6AV,5N]HQV5E7G4\3O1J+ALCH:3=J[*VG1>9Z?W143HL9:6
MQ&2^#H^5W(XZO)\T<L]?=TJPVUSGPE?R2W/%3Y7GGDCJ[^A5^6 @(
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M/%V[O)$\?1/%/J=/"*BHBHNZ+W*>?U]O]
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M\)5IPHG2=/5ZDE30MZ
M              J-\IYF-0M5I?I_#(YM(V*LR"XP^#Y'*E+2N_D(DW\XLO\
MT_PL:7;W+Q4^^?<K?;W$SK:L]-7NCWJG2QU=     ].S7>OQ^\6J_6J=::Z6
M2L@K[;4IWQSTTB2Q/^AS44X7;=-VB:*MTQI/1+G:N56ZXKIWQ.O8ZI\;O4.2
M8[8<BIFJRGOUNI;C3L]3*J)LK4_$X\ZW[4VKE5$\DS'8]"V+L7;=-<<L1/:]
MHZG:
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M)9(:"%CE7JO7=/6>>\TKBO%W:HY:ZO:E?^6431A+5,\E%/LPV08+.
M
M                                        '\N<UC5<Y4:UJ;N<O1$1
M .=KB_UWDUPU4K9;75NEP;#UEM>'1-7>.5B._9%:GMJ7M14^T1B+U0N_9C)_
M]NPL<*/UE7'5[HZN_52FTN;_ .X8J>#/ZNGBI]\]?=HBD2-'0
M /IHZ.KN-926^WTM16U]=,RGHJ*!BR2RRRN1K(V,;NKG.<NR(A\JJBF-9W0Y
M4TS5.D;Y7^<'_"_1:%XLF09)3T]5JAD\#5O-3\)+;3.V<V@A=W=%3>5R?"=T
MZM:U5IC:?:"<QN\"CYJG=_%/VI]WXKCV:R",NM<.OYVK?YH^S'O3/(JE
M       5R^4RI6OT6PNMYEYJ?-::%&>"I-;J]RK]'9DYV!J_]VN/_C_NI0C;
MNG_TZ)_C_MJ4BELJI      NC\F;F2W+3O/<&FDYY<5O<-SI4=X4]UAY>1OL
M22D>[YW?,55M]A>!B+=[[5.G73/PGU+2V#Q7"P]RU]FK7JJCXQZUF) D[
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MWVS=]E]IYZQ6'JP]VJU5OIG3L>@,-B*<1:IN4[JHU[62G0[P
M                                          *[?*-:7566:6V34"UT
M_;UVF];(MS8UOI>YEQY(YG].J]E+'$OL:KW=-E)OL-F$6,559JW7(XO2C=VQ
MKZD*VWR^;V&IO4[[<\?HS\)T]:CTMM4X    -MZ%Z95NKVJV&X)2Q/=372N9
M)?)V_N%N@7M:R55]D351OK<J)XFMSC'Q@<+7>GDCB]*=WK;+*,!..Q5%F.6>
M/HC?ZG3M'''%&R*)C(XHVHV.-J;-:U.B(B)W;'G^9U7W$:/[
M
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M51V3Q=^B9;$8CP>-FC[5,]L<?=JO4*A6V
M               AKQTZH?J=:#WNVT50D-^U#D^IVW-1?32GG:KJZ3;OV[!'
M1[^"O:2G9#+_ )5CJ:I\FCQIZ?J^OCZD8VMS#Y+@:HCRJ_%ZOK>KBZW/J72I
MD    %WODX=3ER72Z]Z<U]0LEQT\KNTMS7+U]S+DKY6(GKY)VR[^I%:G3H5+
MMUE_@L53?C=7''Z5/X:+7V'Q_A<-58G?1/\ 35^.JQ<@Z;
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MI]H/]RN\"W\U3N\\_:^'XKAV9R#_ &VWPZ_G:M_FC[/Q_!,XBJ4
M
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MGZ9Y.U+]E<A^77/#78_5T_U3S=$<O8OA:UK&HUJ(UK4V:U.B(B%.K>?T
M        $%_*'PQR\.=6][>9U/D-KDA7Y+E61F_\URH2[8B=,QCT91+;6/\
M^?\ S0H3+D4^     !O;ACR7ZDN(#22]+(L4?U1TE!42I\6&Y+YC*J^SDG7?
MV&HS^QX? 7J?X9G[OC>YM\AO^!Q]FK^*(^]Q>]TO%"+V
M                          4+^4#U17.=:WXE15':6/3*F]RXVM7=KKC/
MRRUS_G1>2)?;&7'L7E_R?!>$GRKG'U?5]\]:H-LLP^48SP<>3;XNOE^'4@F2
M]$0    2IX,]3OU,->\2JJJH["QY8Y<:OWR>SKW-2!Z^I&5+8G*OR44CNU.7
M_+,!7$>53XT=6_U:I#LOC_DF.HF?)J\6>O=Z]'164>NP
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MU?D[D)S//,5F,_K:N+[,<5/9\=933+,DPN7Q^JIX_M3QU=OPT;R-0VP
M
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MZ?[B9B/;^13SE<HFBJ:9Y'HBW7%=,51ROO.#F
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MVFI;4
M
M                                                      PK4;.[
M)IE@^39YD4J1VK&J*2KF9OLZ9Z>C# S?X\TBMC;[50RL#@Z\9?ILT;ZI_,]6
M]BXW%T82S5>KW4Q^8Z]SF-SS-+WJ+F61YQD<_;WG)JZ2MK%3?E9SKZ$3-^YD
M;$1C4\&HB%_X/"T86S3:HW4QI^>G>H7&8JO%7JKM>^J=?ST,2,EC
M    ^FDI*JX5=+04--/65M;*R"CI(6J^2661R-8QC6]5<Y5V1$/E544QK.Z'
M*FF:ITC>Z)>$[A[H]!-.H::X0P29[D[8JW-+@W9W)(B+V5$QR?$IT<J=/A.5
MSNY4VH_:3.IS+$:Q\W3Q4_'K[M%U[.Y+&6X?2?G*N.KX=7>E,1Y(
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M#3R^-'3NGU:=BX K%98
M
M
M       !3CY1O6];M?+7HC8:M?,,=='=,U5BIM+72,WI*953^XQOYW)W<SV^
M+"T-ALIX%$XNN..KBIZ.6>N>+J\ZLMM\VX=<82C=3QU=/)'5''U^95R6$K\
M           "U'R>O#JVZ5?ZN^74#9+?;99*?3RCF3=LM5&JLGN&R^$*HL<?
MV_,[HK&J5WMMGG CY';GCGR^CDIZ]\^;I6%L7DG#GY7<CBCR.GEJZMT>?H7!
ME8K+               (.>4,^QQN7W^M7YQQ+=B?I&/1E$]M/H^?2A0<7*IX
M      !T,<"EU]T^&+3YCGH^:U2W6AF7T>G)<JE[$5&]VT;V]_7Q\2D]K[?
MS.YY])_IA=&R-SAY;;\VL?U2EX1E)0
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M%<15&Z7UG%R
M
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M:^EHY^B>K>5?RE0[=T<''Q//1'?5'N6WL/7PL#,<U<]U,K "%ID
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M ";'37'DW/&Z_K>OCZUQ['X_Y3@HHGRK?B]7U?5Q=2;1$TJ
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M^<MU4],3#;6,PP]_YNY35T3$L\,-E@
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MGNM5=!5\J?;I"]RM^932XC!W\/.EVBJGIB8;G#XRSB..U735T3$LN,9D@
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MI_\ 8M3_  ]T_BM#8*K_ ->[3_%WQ^"S@@">@
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M\T+?\(1+;/+_ )3@O"1Y5OCZOK?'J2S8['_)L;P)\FYQ=?U?AUK\BFEP@
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M^&J?97M=A,9XM?ZNOS[NJKXZ)M(J*B*B[HO<I$TK?Z
M              -&<1NL%)HAI/D>:N6)]Y5GN?B=&_;WZZ5*.2#HO>V/997I
M\EBFWR/+)S'%4VN3?5Z,;_ATRU.=YG&7X6J[R[J?2G=\>IS3UM95W&LJ[A7U
M$U975TSZBMJYG*^2665RN>][EZJKE7=5+ZIIBF-(W0HJJJ:IUG?+YCZX@
M        L(X =!/U0L\?JAD5'VF(Z=U#'6R.1N\=9>MD?"WKWI3(J2K]MV?>
MFY"ML\Y^2V/D]$^/<W^:G\=W:FFQV3_*;_RBN/$HW>>K\-_8O,*B6RQ:ZYOA
MUDW;=<GL5#(G[A)4Q]IT_O:+S?D,JU@;]WR:)GJ8MW'6+7EUQ'6P2NU\TNHE
M5K<@DK7IWMIJ6H=_XG,:W\IGT9!C*OJZ=,PU]>T&#I^OKT1+'I^)?3R+?LZ7
M)JK9=D[.FB3?V^G.PR*=F<5/+3V_@QZMI\+')5V?B^7^J?P'_NC+_P#,4O\
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M$IY\?G23?O[9MQ;MM[.S*T_U"IX[$^E_:LG8"KBOQZ/]RU\KA8@
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MFG-%RKS3Y-),C_!$AHY6JGT]H3W8"G_V;D_P^^$$V]J_]:W'\7N4N%JJM
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ME=G(P5'A[T?K9_HCXSR]G/KSVIVBG&U^!M3^JC^J?AS=O-I 0F:'
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MBE??Z@1^ILS_ !3W)_L#/ZZ['FCO7(E7+.
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MG0S1.[_28Y$7JB[HOBG5.A.+-^B]1%=N8FF>6$)O6:[-<T5QI5')+QCM=0
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M$<<^ITWP0PTT,--3Q,AIZ=C8X(6)LUC&ILUJ(G<B(4#,ZSK*^8C2-(?J?'T
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MOK&*O^+E:B>Q$*+VGQ'A\QNSS3P?N\7N7ALSA_ Y=:CGC7[W'[TES0MZ
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M=(GKYG]DU%^U<GK*SV]S#6:,-'I3W4^_U+)V$P&D5XF?1COGW>M:Z5RL0
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M\JM:OP2]-G,J_P!NPE-$^7/'5T\W5N4?M%FO^X8N:X\B.*GHY^O>C4;YH@
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MH=G+F65<*GQK4[IYO-5\>5;^S^T5O,J>#5XMV-\<_GCX<B7I&4E
M         !I#B,U19H]H[FF:QS-BN]/1K18TB[*KKE6>\TRHU>_D<[M')\EJ
MFVR/+_EV,HM<FNL^C''/P:K.\P^0X2N[RZ:1Z4[OBYG9)))9'RRO?)+(Y722
M.7=SG+U555>_<OR(T4/,ZOX ^FCI*FX5=+044$E365LK(*2FC3=\DLCD:QC4
M]:JNQ\JJBF-9W.5-,U3I&]T^:+Z=TVE&EN$X!3I'VF/6R..Y2L^#+72[S5DJ
M>Q\[WJGL//V:XZ<;BJ[T_6GBZ-T>I?F5X*,%AJ+,?5CCZ>7UMGFO9X   5[>
M48TT^JK2&VYY14_:733>X))4O:BJ[W-N*L@GZ)\F5(7>Q$<OK)KL/C_ XN;,
M[KD?U4\<>K5"]ML#X;"1>C?;G^F>*?7HHT+=5,    #UK#>[EC5\LV1V>H=2
M7>PUM/<;75-[XZBFD;+$[Z'-0Z[UJF]1-%6Z8TGHEV6;M5JN*Z=\3K'3#J(T
MWS>VZDX'B6=VG9*+*;9!7-AWYNQD>WWZ!R_*BD1S%]J'GS'82K"7Z[-6^F=/
MQZ]Z_P# XNG%6*+U.ZJ-?PZMS-C$90      #R,@_L#>_P"(5/YIQV6?+IZ7
M7>\B>ARA'HYYV    !]=!15%RKJ.W4;.UJZ^>.FI8OE22N1C4^E5.-=<41-4
M[H<J*9JF(CE=4F&XU1X9B.+XC;T3S+%[51VJE5/%E)"V%%^GEW/.V*OS?NU7
M)WU3,]LZO0F%L18M4VXW4Q$=D,E.AW@    YL^+*P-QKB.U=MS6=FD]]?<T;
M]](XZ_?P[_."]]F[WA<NLU?PZ?=\7W*,VCL^"S"]'\6OWO&]Z.YNVE    !T
M?\(&+LQ/APTKHDCY);G:O=NH>J;*];K*^M:J_P B5J)[$0HO:;$>&S&[/-.G
MW>+W+PV:P_@<NM1SQK][C]Z2IH6]    ! 'RCF+,O.A%%D#(VK4X=D5'4NF\
M4IZQLE)(W^5))$OT$SV&Q'@\=-'VJ9[8X_BAVV^'\)@8K^S5'9/%\%%);ZHP
M    3B\GI6>:\1]L@[7L_=&PW6GY/[IRQMFY?_A;_01';:G7+I\U4?#WI9L7
M5IF,>>F?BOR*;7"   &HN(!C'Z$:U(]K7HF"9$Y$5-^K;;4*B_0J&SR7]NL?
M]E'M0UN<_L-__KJ]F7,07^H0    %AODTF,=KOE*N:URQX)7NC54[E]TK8FZ
M?0I"=O?V&C_LCV:TTV$_;JO^N?:H7CE1K9   #\IYH::&:IJ)60T].QTD\SU
MV:QC4W<Y57N1$/L1K.D/DSI&LN8+6K4.HU6U4SC/IGO=%?[G*^V,?OO'0P[0
MT<?7Y,#&(>@<JP48+"V[/-''T[Y]:@\UQLXS%5WN>>+HW1ZFK38->    "\3
MR;6'LLVC609;)%RUF9Y!*C)OE4=MC;#$GT3.G*DV[Q/A,93;Y**?75Q]VBV-
MAL-P,'5<Y:ZO5'%WZK$"$)J        >=46BU5<JSU5LM]3,[;FFEA8]R[=W
M54W.<7*HW3+A-NF=\/IIJ2EHX^QHZ:GI8M^;LH6(QNZ^.S=CC55-6]RBF*=S
MZ#X^@  !S[\?7V3>8_Q"S_H$)=.QOT91TU>U*FML/I*OHI]F$,R4HN    #J
MRQ"E\QQ+%Z+G[7S.T44':;;<W9P,;OMUVWV/.F)JX5VJ?//>]#X:G@VJ8\T=
MS(CH=P     '+?J[^VQJ?^%MZ_3ICT+EG[+:]"GV8>?\R_:KOIU>U+79FL(
M  -U\-U/%4Z_Z,QS(KFMS&SRHF^WI15<<C?_ !-0U6>SI@+_ *%7<VN1QKC[
M/IT][II*"7P  (#>4=^Q]H_PMMOYBK)EL+](3Z$]\(?MQ^P1Z<=TJ)"X%1
M !F."Y_F.FF14F58-?Z_'KY2>BVKIG=)(U5%=%-&[=DC';)NUZ*B^HQL9@K.
M+M^#O4\*G\[N9DX3&7L)<\):JX-7YW\ZV[1;RC6(WYE)9=9;4N'7?9(URJW,
MDJ+7,[Y4L*<\]/O[.T;XJK4*TS78:[;UJPL\*/LSQ5=NZ?5UK(RO;>U<TIQ4
M<&?M1QT]F^/6L8QS)\<R^UP7S%;]:,CL]3]8N=MJ(ZF%WK3GC5R;IXIWIXD'
MOX>Y8JX%RF:9YIXDWL7[=^GA6ZHJCGCC>Z=+M
M            01X]M;OU-=+%PFR5O89?J6V2A;V:^^4]I:FU;-[.T14A;]TY
M6]6$PV-RGY7BO"U1XEOCZ:N2/?U>=$=L,U^287P5,^/<XNBGEGW=O,H9+B5
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M*USJ5VBR"O++O%QVJO)G^V?/W]JYMGL^IS.UQ\5RGRH_NCS=W8E>1Q(@
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ML7Y3&2N?_)-[LUA/E.86J9W1.OW>/W:-'M)BODV7W:HWS&GWN+WZN;HO51P
M    '2CPI6!N-\.>D%N:U&)48]!=-NG?=5=<%7IZ_."A]H[WA<QO3_%I]WQ?
M<O39VSX++[,?PZ_>\;WI!FE;D               YYN.R>6;BDU)CD=S,I8[
M+% FR>BU;/12;?SGJI=NQ\:97:_F]NI2VUTZYG=_E]BE$0DJ-@    ZO<?\
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M7;)S-5';)OL45FN67,NOS9KZIYXY)_/*O'*LSMYA8B[1UQS3S-M&M;$
M          Q[+,FM6&8QD&6WN9*>T8W;ZBXW"551/>J>-9%1N_>Y=MD3Q7H=
MV&L58B[3;HWU3IVNG$7Z;%NJY5NIC7L<O&=YA==0,SR?-KV]77/*+E47&J;S
M*Y(^V>KFQ-5?BQMV8WU(B'H3!X6G"V:;5.ZF-/STJ Q>)JQ-ZJ[5OJG5B9D,
M< O8\G?IG]1^C%3FM9!V=VU+KUJV*J;.2W4*OIZ1J]-^K^VD3UM>A4&V^/\
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M5#MM3IF'\L>] \F"(     ZO<?\ [ V3^(4WYIIYQO>75TO1-GR(Z'KG6[
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MAFAD3F9)&]NZ*BHO12I[ENJW5--4:3"U;=RFY3%5,ZQ+[S@Y@
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MSIW)\)?9W)[5ZDAPN"IL\>^6CQ&+JN]#4YFL0
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M<MYZ%>?P    63>3*_;8S[\$E_3J8@FWW[+;]/\ ME.=@_VJYZ']T+KBJ%J
M  !39Y3UDR9KI8]4?YNZR5S8W?%YTJ6<^WMV5N_T%H_Z?_,W?2CN5CM]KX:U
MZ,]ZKXL%      >OC_\ 9ZR?Q^F_.M.N]Y%70[+/EQTNKT\XO1(
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MK^J4M*WI# SY$;?!/RKXDELV*;5.E+0W;U5V=98P=KJ
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M]J6J38M<   &\N&?[(+1O\+;9^?::C/_ */O^A/<VV1?M]GTX[W3$4(O<
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MRWY!C:[<>3/'3T3\)UCJ7EL]F/R[!T7)\J.*KICX\4]:1)I&[
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M?!/_ *DGM6J;=/!I1^Y<FN=9>*<W
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M0VTS#Y/@O!QY5SBZH\KW1UI=L;E_RC&>$GR;?'USY/OGJ7TE.+?
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M1+*B[^I^Z'GS-+/@<7=HYJZN]?\ E=WPN$M5\]%/<V48#.
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M-5>S@B3X,<:+X)^5>I*+-FFU3P81Z[=FY5K+&3M=0
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MU7 ?Q0TZL2+3VDKN;?=8+S:4Y?G[6KC_ "';3MAED_\ )I_+5\'75LAF<?\
M'_53\6/U?!AQ-T2S)-I1=7]@F[^PK+?4;]-_1[&J?S?1N=U.U665?\T=DQ[G
M35LOF5/_ !3VQ/O8O6<+_$-0_7]'<]?LQ7_L>@DJ.B?X'GZ^SO,BG:#+ZO\
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MG1Z/>=0    3,X!?LF\._B%X_0)B+;9?1E?33[4)1L?])4=%7LRZ""EER@
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ML&OUVAC5.2LPZX13I]JE712)^5B$+V[IUP$>G'=4F6PU6F.GT)[Z5ZA4*VP
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M^+J^K\.I. B25@  !Y&0?V!O?\0J?S3CLL^73TNN]Y$]#E"/1SSL    "7G
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ME.]ZK_@T('MW@/"8>F_&^B=)Z*OA.G:G6PV/\'B*K$_7C6.FG\->Q=852M,
M              YE>)"@?;M?M9J=_/O)F5YJDYDV7:JJY*A/R2="_<BKX6 L
M3_!3ZHT4/GE'!Q]Z/XZO7.K2IM6J    !T;<&^7QYEPXZ:57:\]38J!;!6Q[
M[K&ZU/=31-7YX61N^94*-VHPW@,QNQSSPOO<??JN[9C$^'R^U/-'!^[Q=VB3
MQ'V_    !#SCJSJ/"N';*Z5DB,N.;34^.6Y-^]*EW:U/3U>;0R)\ZH2?9#!_
M*,PHGDH\;LW>N81G:W%_)\OKCEK\7MW^J)<]Q=:F     ;EX=:I:/7S1B5&(
M_GS6QP;;[?7ZZ*+?Z.;<U>>4\+ 7_0J]F6TR2K3'6?3I[X=-Y0*^0
M    8?FV 89J/9)\<SG&[7DUGGWWI:R/F5CEZ<\,B;/B?ZG,<CD]9DX3&7L)
M7P[-4TSYOSQ];&Q6#LXJC@7:8JCS_GBZE+G%/P1W72&EK<]T[FKLDT[B=VET
MH)DYZ^SM<J^D]6I[]3I_=-D<WXZ*B*\M79W:RG'3%F_XMSDYJOA/FY>3F5;M
M!LI5@8F]9\:WR\]/QCS]O.K^)HAH   3^\F]!+-K_=)(V\S*7#KC+.NZ>BU:
MJBCW_G/1"&;=3I@(]..ZI,MAXUQ\^A/?2O6*@6V
M 5"^4@UL;55EFT.L54O9VYT5ZSAS%Z+,]N]#2.V^2QRS.1>GI1KWH69L+E.D
M3BZ^7BI_NGW=JMMN,UUF,)1R<=7NCW]BJ4L978           ,KPG%ZG,<EM
MMAI^9C*E_-63I^Y0,]*1_P"+N]NR'3B+T6J)J=MFUX2N*5DE'1TUOI*:@HX6
M4])1Q,AIH&]S&,3E:B?,B$4JF:IUE)(C2-(?2?'(  1AX@,^6D@;@]KFY:BK
M:V6_2L7JV%>K(/Y?PG>S;P<;?+,-K^LGJ:O,,1IXD=:(INVH
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MS8FKOXH4?M5COE685SR4^+'\N_UZKLV7P7R7 4<]7C3_ #;O5HE41U(0
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M&X/8(E794]**WP1O3KZG-5"@,[C3'W_^RKVI7UDLZX&Q_P!=/LPW :QLP
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MXAYU^4]M4[;V,]A:.P&*UM7;/-/"[>*>[UJQV]PNEVW>YXX/9Q^_U*NBP4
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M^58^K3=1XL=6_P!>JZ=E,#\EP%.N^OQIZ]WJT2Z(TD@
M   "G'RC^M+;M?;)HK8JQ'T..JR[YDL3NCJ^5BI2TSMO[C$Y9%3NWD;XM+0V
M%RK@458NN..KBIZ.6>N>+J\ZLMN,TX==.%HGBIXZNGDCJCCZU7)82OP
M      9[IMA[\URN@M3FO]SHE\YN\K?BT\?PDW\%>NS4^<QL7?\  VYGE=^&
ML^%KT6,1QLAC9%$QL<4349'&U-D:U.B(B$62-_8?0 !"_B"S);K?8,5HY=Z"
MP^G7(G<^L>G_ /&Q=OG5QOLLL<&GASOGN:7,+W"JX,<B.YM&N
M    /]1%<J-:BJJ]$1 -ZX3H1D>1)%77YSL<M3_2:V1N]7(GVL2[<F_K=_-4
MUV(S&BCBIXY]3/LX"JOCJXH2PQ7 L6PV%L=DMD4=1R\LMRE]\J9/7S2+W;^I
MNR>PTM[$UW?*EM;5BBWNAF1T.\     "'/$I(BY%CL.R[QVY[U7[N54_^TWN
M4^1/2TV9>5"-IM6M   #J,T<IF46D.E='%&L,=)A]CACB7?=K64$+43KUZ;>
M)Y[S2KA8N[/\=7M2O_+*>#A+4?P4^S#9!@LX
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MY_FEOA[_ (*-H:^7?_P;?2378.G7'U>:B?:I0S;FK3 T^>N.ZI1B6ZJ4
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M=745]54UU7*Z>JK)7S5,SN]SY%YG*OSJI+*8BF-(1J9UG5\Q]?
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M42RXE3R?"_Z1N2)],<#5_P#$NWS&YRJUOKZFIS*[NH12-RU0
M #>^F6B]?E?87K(.VMF.KL^&/X-16)]IO\%B_*\?B^M-=B\?%OQ:>.>YGX;!
M3<XZMR:%JM-MLE#!;+3104%#3)M#30ILB>U?6J^*KU7Q-!77-<ZRW5-,4QI#
MT3BY         "N'4RYI>,^RJM:O,SS]]/&[UMIMH&K^)A*L)1P;5,(WB:N%
M<F6"F0Z  !^D44DTD<,+'22RN1D4;>JN<Y=D1!,Z/L1JZRJ>"*E@@IH&\D%/
M&V*%FZKLUB;(FZ]>X\W3.LZR]%Q&D:/V/CZ
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M5]+F^%4K4=WQ?KW=]/B4QMI1P<RJGGBGNT]RX]C:^%EU,<TU=^OO38(HE0
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M_5RJY:@S?.K^9W.%<GBY*>2/Q\ZW,IR:QEMO@VXX^6KEG\/,WF:AM@
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MW,I(HL2PK*\E=,NT?N9;ZBJ3V[NB8Y$1/%5[C&OXVQ8^<KIIZ9B&38P5^_\
M-T55=$3*5> \ /$!F+X9KY:[3I];'JBNJ;U4M=4*SQ5E+2]L_F]DG)\Y',9M
MG@+'D3-<^;=VSIZM4BP>QV/O^5$41Y]_9&OKT6":3^3YT=P1]+<\SDK-3[[
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ML,3G-3=4:ZX0(J_0G4U^;U<'!7I_@J]F6PRFGA8RS'\=/M0Z@CSZOT
M
M
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M3JU&ILU$6.)NVR'3<Q^(N>7<JGIF9][NMX##V_)MTQT1$,W,1E
M           ,0N>G^!7J19;SA&(W:5SN99*VVTL[E=W;[R1N,FWC;]OR:ZHZ
M)F&-<P=BYY5%,],1+%4T%T,1Z2)HOI.CT7F1_P!3MLWW]>_FYD_[SCOW]S[]
M7Q8_^SX+]Q;^[3\&36_3G3VTR=K:L#PRV2[[]I26NDA=OW=[(T]9CUX[$5^5
M<JGKEWT8'#T>3;ICJAF2(B(B(FR)W(8K*?Z
M-8ZR:F6S2#37*]0;IV<C;#1N=;J)R[>=5LOO=+3^OTY7-1=NYN[O S\KP%6.
MQ-%FGEGLCEGL8&9X^G X>N]5R1VSR1VN8Z^WNYY+>KOD5[JY*^\7VLGK[I6O
M^%+45#UDD>OSN<I?]FU3:HBBF-(B-(Z(4+=NU7:YKJXYF=9Z9>4=CK
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M?Q\/>^OL-+M'7P<NO3_#W\3<[.T<+,+,?Q=W&Z4"AUZ
M
M
M
M         !3-Y1_65M\R>R:,V:I1]OQ%6W;*E8NZ.N4\:I3PK_@8)%=\\FW>
MTM/87*_!VJL55OJXJ?1C?/7/<J_;C-/"7*<+3NIXZO2G=V1WJQ"?H$
M     "=' 7HG^J9JNS,;Q3=IB>F3H;E,CV[LJ;FY56A@Z_(<Q9G=_P !J*GI
MD0VQS;Y)A?!4^7<XNBGZT^[K\R6[(95\KQ7A:O(M\?35]6/?U>=?84XN  \#
M*<>HLKQ^ZX]<-_-KG L:O3O8]/2C>GM:Y$4R,+B*L/=IN4[X8^*P].(M56ZM
MTJM;U:*ZP7:X66Y1+#76V=T%2SVM7O3UHO>GL+3LWJ;U$5T[I55>LU6:YHJW
MP\P[74@AKY=5N&H573([>.S4E/1L^=6]N[\LI(\MHX-G7G:''U:W>AI8SV$
M         &?Z<8/59WD4-M;SQ6VFVGO%8G[G"B_!1?E/[F_C[D4QL5B(LT:\
MO(R,-8F[5IR+#Z*BI+;1TU!0P1TM'1QMAIJ=G1K&-39$0B]54U3K*0Q$1&D/
MJ/CD           #56K^:?4=B=0M+*C+S>>:CM7RF[I[[,GW#5Z?;*TS,#A_
M"W/-#$QE[P='GE7X29'P    2YX%K>E?Q0:<*]&.CH&W:KD:Y53X%KJD9MMX
MH]S5(UM?7P<LN^?@^U"2;)4<+,[?FX7LRZ&RDET@
M
M
M
M    #76K.HELTGTYRW4&[(V2GQNA?/!2JO+YQ4O5(Z:!%_OLSFL^DSLMP-6-
MQ%%FGZT]D<L]4,+,<;3@L/7>J^K';/)'7+F*R/(+KE=_O637VJ?6WF_UL]PN
ME6[O?/4/61Z^SJO1/ O^Q9ILVXMT<44QI'4H2_>JO5S<KWS.L];Q3M=0
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MUQW3/N3#8BCA8^9YJ)[XCWKW"GUN@
M
M
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MY/JBJHU^,U=TID7V+U?_ #?E(;K+<)_R5=7Q:G'XGZD=:+!N&J      L_\
M)AVM9<XU1O7Q;?8J*B7YZRI=(GA_ZMZ__P"J_P#]0+FEBU3SU3/9'XI]L%;U
MO7:N:F([9_!<J5:L\
M
M
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MPW&X,2QJTV&#D5:*%/.96_ND[O2E?]+E7Z")W[OA:YJ26S;\'1%+)SJ=H
M        -%:P:J1XE226&R3LDR:M9M)*U=_,HW)\-WVZI\%/Y2^&^QP.#\+/
M"J\GO8&,Q7@XX,;^Y!Y[W2.<][G/>]5<][EW557O55)"T;^0      7&^3!M
M'8XCJO?^7K<KO;:#G]?F,$LNW?X>=^K_ /JK_P#4"[K=LT<T3/;,?!9NP-O2
MU=KYYB.R)^*T<KU8
M
M
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M^Y"*IJ:BMJ)ZNKGEJ:JI>LE142*KGO>Y=U<Y5[U4D$1$1I#23.K\#Z^
M  +Z/)V67W+X=HJ[;;ZI,EN=QW]?(D-%ZU_[+[/_ *K3NW%WAYAI]FF([Y]Z
MW]B;7 R_7[54SW1[D["'I<                              *![OQY<2
MU)=;G2P9A:6PTU7-%"U;10+LUCU:G7L?4A<UO8[+9IB>!.[[4_%3MS:_,8JF
M.''W8^#S_P"KZXF_WXVC^AZ#_@G/]#<L^Q/WI^+A^F&9?;C[L? _J^N)O]^-
MH_H>@_X(_0W+/L3]Z?B?IAF7VX^['P/ZOKB;_?C:/Z'H/^"/T-RS[$_>GXGZ
M89E]N/NQ\#^KZXF_WXVC^AZ#_@C]#<L^Q/WI^)^F&9?;C[L? _J^N)O]^-H_
MH>@_X(_0W+/L3]Z?B?IAF7VX^['P/ZOKB;_?C:/Z'H/^"/T-RS[$_>GXGZ89
ME]N/NQ\#^KZXF_WXVC^AZ#_@C]#<L^Q/WI^)^F&9?;C[L? _J^N)O]^-H_H>
M@_X(_0W+/L3]Z?B?IAF7VX^['P/ZOKB;_?C:/Z'H/^"/T-RS[$_>GXGZ89E]
MN/NQ\#^KZXF_WXVC^AZ#_@C]#<L^Q/WI^)^F&9?;C[L?!8IP,:ZZD:WVK4:J
MU%N]+=IL>J[;%:G04D%+R-J&5#I-T@8SFW6-.\@^U^48;+JK<6(TX43KQS.[
M3G3;9+-\1F%-R;TZ\'33BTWZ\R>A#DO ,*U)N==9=.L^O-KJ'4ESM..72MMU
M4U$58IX*262-Z(Y%3T7-1>J&5@+=-S$6Z:MTU1';+%QUR;>'N54[XIF>R'/]
M_5F\3?\ "Q=_]$H/^6+H_1;+/W,=L_%3?Z49E^]GLCX)8<%W$;K5J7K?08OG
M.>7#(+#+:+A426Z6GI(VK+"QJL=S0PL=T^<C>U61X+"8*;EFWP:M8X^/XI%L
MOG>,Q>-BW=N:TZ3S?!<,5BLP
M
M        !CV6U]5:<4R:Z43TCK;;::VJI)%1'(V6&![V+LO1>J'=AJ(KNTTS
MNF8[W3B:YHM551OB)[E#']7UQ-_OQM']#T'_  2X_P!#<L^Q/WI^*H/TPS+[
M<?=CX))<)G%GK?JMK?C>%9KD=ON./7&DN,M52Q6ZDIW.=3TDDL?OD4;7)LYJ
M>)H=I-F\%@L%5=M4S%43'+,[Y;S9S:/&XS&TVKM6M,Z\D1NA;L5HLD
M                                   !C>8Y5:,&Q7(<POTZ4]GQJ@GN
M%PDZ;\D#%=RMW[W.VY6IXJJ(=^%P]>(NTVJ-]4Z.C$XBG#VJKE>ZF-7,#J'F
M]XU)S?)\[OS^:ZY/7RUM1&B[MB:Y=HH6*OQ8HT:QOL1#T#@L)1A+%-FC=3&G
MX]>]0>-Q=>+O57J]]4Z_AU;F&F4Q0          ^R@H*RZU]%;+=32UEPN4\
M=+04<2<SY9IG(R-C4\5<Y41#C77%%,U5;H<J*)KF*8WRZ8M -)Z/1;2G%L$@
M2)UPHX/.LCK&?]8N=3L^I?OXHCO0;]HUI0>=9E.88JN]R<GFIC=\>E>^39=&
M PM-GEY?/5._\\S<QJVT       <MVKEA7%M5-2<<Y>1MDR>ZT<2)W=G#5R-
M8J=W16HBGH7++WAL+:KYZ*9]3S_F5GP.*N4<U4QZVO#-80       !85I%C'
MU+X/:H)8^SK[FGNA<$\>>=$5K5^Y8C47VD8QM[PEV>Q(<):\';ALXQ&4
M     /U@@GJIHJ>FAEJ*B=R,A@C:KWO<O1$:U.JJIQJJBF-9?::9JG2$3M3-
M=E_95APB56JBNBJ\B[E]3DID_P#O_F^#C=X3+OK7.SXM1B<=]6CM16>]\CWR
M2/=))(JN>]R[JJKWJJFY:I_         #I,X3+#]3?#AI#;^7E\XL,=TV^^L
MC[AO]/G!1&TE[PN8WI_BT^[XON7GLY9\%E]F/X=?O>-[TB#2-T
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M>?TXO)Z?9'VS[PW7\VTB.VWT=/I0EFQ?TC'HROR*;7"
M
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M9E9+0^/M*1TZ3W!/#S>'TY$7[I$Y?I,?%7?!6YEWX>WX2Y$+("*I(_T
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M
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MT6.QEN;5ZYK3/)I3&[HB)96#V?P.$N1=M6]*H\]4[^F92"-*W(
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M=U\2_P#*\!3@<-19IY(X_//+/:H3-,=5C<37>GEGLCDCL:P-@P
M ^JAHJNY5M);J""2JKJ^:.FHZ6--WR2RN1C&-3UJJ['&NJ*(FJ=T.5-,U3$1
MOETR: :3T>BVE.+8) D3KA1P>=9'6,_ZQ<ZG9]2_?Q1'>@W[1K2@\ZS*<PQ5
M=[DY/-3&[X]*]\FRZ,!A:;/+R^>J=_YYFYC5MH        59^4TP!]9CFGVI
ME)#NZR5D]@O+TZN[&L;V]*Y?4UCXI$^=Z%A[ XW@W+EB>6.%'5Q3WQV*_P!O
M,'PK=N_')/!GKXX[I[5.Y9ZL@      $K.&NPI_Z0Y/*SKZ%MHI/Q2S_ /\
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MH+M;JE.:GKZ.9D\,B>MLD:JU?H4TURW5;G@U1I/G;BBY3<CA4SK'F?><',
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MQLOGE'J-+SMMB>#\^,LD])'*ZF?OR)\79:N9>OBBKZB<4SX/9R>#]:YQ]O\
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M";[$99X?$S?J\FWN]*?A''V(5MKF7@,-%BGRKF_T8^,\7:H[+;5.
M   "P3R>^C'U=:GSZCWBD[3&],^2>AYT]":\S(OFJ)OW]@U%F7;N=V?K(7MK
MFOR;#> I\JY[/+V[NC5,]C,K^48GP]7DV_:Y.S?V+T"H5M         #4FNV
MG+-6-(\[P+E8M7>[8];.YW1&W"F5*BC55\$[:-O-[-S99/COD6+MWN2)X^B>
M*?4UV;X+Y;A+EGEF.+ICCCUN8N>&:FFFIJB)\-13O='/"]-G,>U=G-5%[E12
M_P")B8UA0DQI.DOR/KX     !>MPL\..)5/#]@-?D=-<(+]DE++>9ZNEF6->
MQK9GRTOHN1S/ZW6/XI4F?[0WZ,?<IMS'!IG3C\V_UZK6R+9VQ<P-NJYKPJHU
MXO/N]6C;-9PM8\]5]S\HO-*WP2HBBG7\;>Q,&C:F[]:B.[XLVO92U]6N>_X,
M>EX5:I'>\YM3R,V[WT"L7?YDJ'&3&U<<MOU_@QIV3GDN>K\7XIPKW+=W-F-"
MC4^ J4;U5?G3M>A]_2JC]W/;^#C^BE?[R.S\7V4_"J[OJ\W:B;]616_?=/NG
M5"?ZCA5M7S6_7^#G3LGSW?5^+*:#A?P^%4=<+YD-<J?%B6&!J_/[V]?RF+7M
M1?GR::8[9][+M[+6(\JJJ>R/<V%:=%-,[.K7Q8O2ULK=MY*][ZK?;ULE<L?_
M (377<[Q=SZ^G1Q=W&V-G(\';^IKT\??Q-F4E'24$+::AI::BIV? IX&-C8G
MS-:B(:RNNJN=:IU;2BBFB-*8TA])Q<@"!_'7Q!QZ6Z?R8%CU;R9YJ#320-=$
M[WR@M3O0J*E=NJ.EZQ1_RG(N["8;(9+\LQ'AJX_5T>NKDCJWSU<Z([79S\CL
M>!HG]97ZJ>6>O='7S*&RXE0          !/?R=&+>[>OLM^DB1T.&8]75T<Z
M_%J*I64+&I[5CGD^A%(;MQB/!X#@?;JB.J/&]T)AL3A_"8_A_9IF>N>+WRO=
M*?6Z                                    0<\H9]CC<OO]:OSCB6[$
M_2,>C*)[:?1\^E"@XN53R?'DXOL@JS\$KE^?I"&[=?1\>G'=*8[#_M\^A/?"
M]PI];@      #7>KO[4^I_X)7K]!F,W+/VJUZ=/M0PLR_9;OH5>S+EO/0KS^
MG#Y/543B.MJJNR)8;KNO^+:1+;;Z.GTH2S8OZ0CT92/XI>/2JH*ZY:?:%UU.
MCZ1SZ:^:BM1LR*].CXK8B[MZ=RSKO_>_"0T6SVQT51%[&1T4?Y?#MYF\V@VO
MFF9LX2>FO_'X]G.JDO-\O61W&HO&0W>YWV[5:\U5<[A/)4U$B_;22JYR_C+&
MM6:+5/!HB(CFCBA7=V[7=JX5<S,\\\<O*.QU@&789GN9Z=WB*_X/DMWQB[1;
M?LJAF6/M$3XDK/@2-^U>BI[#&Q6#LXJC@7:8JCS_ )XF3A<9>PM?#M533/F_
M/&NNX1^,BGUJ?'@.>QT5IU+IH'24-7![W2WJ*%.:1T<?[G.QJ<SXTZ*F[V;(
MBM;5&TNR\Y?^NL\=KUT_&//U3Y[4V;VGC'_J;W%=]57X^;KA/@AJ8     ^.
MOKZ&U457<[G64MOMU!$^>NKZE[8H88HTYGOD>Y41K43JJJ<J**JYBFF-9EQK
MKBB.%5.D0J/X@_*'W&>JK<6T&:RCH(E=%4:AUD//-/X*M#2S-VC;ZGRM5R^#
M&]ZV7DNQ%,1%S&;_ +$?W3'=';*M\YVUJF9MX/=]N?[8]\]D*QLCRG)<PN<U
MZRN_WC)+M/\ 7;C<JF2IF7V<\KG*B)X)W(3^QA[=BG@VZ8ICFCB0*_B+E^KA
M7*IJGS\;P#N=(![%CR"_8Q<H+QC=ZNV/W>F_K>Z6VHDI:AGW,L3FN3\9UWK-
M%ZG@UTQ5'-/'#LM7J[-7"HF8GGCBE8SH5Y1++<>J**P:TTRY=CZ[1)EM'&V.
MZTR=R/FC;RQU#43OV1K_ !W>O18+F^Q%J[$UX7Q:OLSY,]'+'=T)QE&VMVU,
M48KQJ?M1Y4=//W]*X3%\IQ[-;#;<GQ2[T5]L%WB2:W7.E=S1R-7\K7(O1S7(
MBM7HJ(I6.(P]S#US;N1I5'(LO#XBWB*(N6YUIGE>^=+N   "._%G]CAJ]]X9
M/SC#=[-_2-GTFEVC^CKWHN;,O=1BVGR7"HB:Z*J[(GU,[K_2Q6W^H7_^?^?^
MQ8W^G_\ S_R?WO(XK>.RX5M9<=.]#;L^@ME,Y]-?=0Z5WOU4[N=';7I];C3J
MG;)Z3OW-6M3F?V[.;(4TQ%_%QK/)1S>EY_-V^;KVBVNJJF;.$G2.6OG]'X]G
MGJTJ*FHK*B:JJYYJJJJ7NDJ*F9RODD>Y=W.<YVZJJKXJ6'33%,:0KZ:IJG66
MU- OV]M%?P\QS_:=.:[.?V&__P!=?LRV.3_MUC_LH]J'3R>?U]@  !6-Q'^4
M!H\/N-QPG1BEM]_O="]U/=<UK$[6@IY6]',HXFJG;N:OQW+R(J=$D0G^1;%S
M?IB[BM8IG=3&^>GFZ-_0@6>;918JFUA>.J-]7)'1S].[I5/YSJ=J#J9<'7//
M,OON45*O62-M9.Y8(E7^XT[=HHDZ]S&HA8^$R_#X2G@V:(IZ/?.^>M76+Q]_
M%U<*]7-73[HW1U,$,QB  #8&!ZJ:C:8UR7# LRON,3<W-+%23+YO*O\ ?J9_
M-#+W=SVJ86,R[#XR-+U$5=_5.^&9A,PQ&$G6S7-/=V;I6T<,W'M1Y[<[;@6K
M\%NQ_)Z]S:>S9=3>\V^NF7HV*HC<OO$K^G*J+R.7ILSHBUMG^QLX:F;V&UJI
MC?3RQT<\>N/.L?(=L(Q-46<3I%4[JN2>GFGU="RP@:=     Y0OJ@OW_ 'W=
M_P#29?\ >/1W@:/LP\[>&KYY2OX'[Q=JKBBTP@J;I<:B!_NUSPRSO>U=K)7J
MFZ*NW>1O:VU1&679B(^K[=*1;)W*IS.UK,_6]BI.7BCX[:3 *VXZ?Z/K07K+
MZ-SJ>^9;*B345ME:JM?#!'\&>=JIZ2KZ#%Z*CUYD;$=GMCYQ,1>Q7%1R4\M7
MGGFCUSYDMV@VNC#3-G#<=?+5R4^:.>?5'G4^Y?F^7Y]=YK]FF27C)KO,J\U;
M<)W3*U%^+&BKLQJ>#6HB)X(6=AL)9PU' M4Q3'F5IB<7=Q-?#NU35/G8L9#'
M -@Z>ZJZAZ575MYP#++MC=7S(L\5._FII]OBU%,_FBE3V/:IA8W+L/C:>#>H
MBKOCHG?'4S<%F&(P=7"LUS3W3TQNE<_PO\;6/ZQRT>%9Y%0XGJ1)Z%"Z->2W
M7=WJIE>Y5CF_O3E7?XBK\%M5[0;)W,!K=L^-:]=/3SQY^U:.0;56\=I:O>+<
M]571S3YNQ/0AR7@     0,XE^.#%]'YZ[#,%IZ/,]1($6.L<Y^]LM4GR:ET:
MHZ65/&)BIM\=S53E68Y#LE=QT1=O>);_ *JNCFCSSU0B&>[66L#,VK/C7/Z:
M>GGGS=LJ<=2M:]4=7*^2MS[,;O>XU?ST]I[3L;?!ZNQHXN6%FWKY>9?%5+1P
M&587 TZ6:(CS\L],[U8X[-<3C9UO5S/FY.J-S5AL&O /Z8]\;VR1N<Q[%1S'
MM7945.Y44"8NC?&]K/I7-345UNLNHN)L5$FL5]F?)4,8G_9J]>:6-=NY'<[$
M^01?--DL'C8UICP=?/3NZZ=W=/G2?+-J\9@YTJGAT<U6_JJW]\>9=+HIKSI_
MKQCKK[A=>]M71\C;[CE7RLKJ"1^_*DK$545KMEY7M56K\Z*B55FN3XC+;G N
MQT3R3^>9:659O8S&WP[4],<L?GG;H-4V@   >1D']@;W_$*G\TX[+/ET]+KO
M>1/0Y0CT<\[):\"_V4^EW^6_]B5Y&]K_ *+N_P OMTI'LE])VOYO8J=#Y2*Z
M@   I^\J#_9[1[^(7G\[2%G?Z?>1>Z:?>K3;_P NST5>Y586(KUT/\"_V+&E
MW^6_]MUY2.U_TI=_E]BE=6R7T9:_F]NI+4C:1@&I-??VB=:OP#R/_9E0;+)O
MVZQ_V4>U#79Q^PW_ /KK]F7,,>@%!@  !+7@7^RGTN_RW_L2O(WM?]%W?Y?;
MI2/9+Z3M?S>Q4Z'RD5U  #$\]<YF#9HYJJUS;%<5:Y.BHJ4TAD8/Y^CTH[V/
MC/F*_1GN<MWU07[_ +[N_P#I,O\ O'H;P-'V8>?O#5\\IB\!MWNM7Q+8?!57
M.X5,+J"[JZ&69[VKM03;=%78B^V-NF,MKTB-]/M0D^R%RJ<QHUGDJ]F5_!3*
MX@   TGKCKW@F@F,+?LNJW3W"L1[<>QBE5JUMPE;MND;579K&\R<\B]&IZW*
MC5VV49-?S*[P+>[EGDC\\D-5FV<6,MM\.YOY(Y9_/+*C+6OBSU=ULJ*NDNE[
MEQO$)7+YOA=G>Z&E[/?HE2]-I*E>[?M%Y=^K6-[BW<JV;PF7Q$TT\*O[4[^K
MFZNU4N:[1XO,)TJJX-'V8W=?/U]B,AOVA  'N8[DN18C=:>^8M?+MCMYI/ZW
MN=NGDIIV^M.>-479?%.Y3JOV+=^G@7*8JCFGC=MF_<LU<.W5-,\\<2U[AAX^
MI[Q<+9@.N4U+'55KVTUGU$:UL$;I'=&,N,;=F,YEZ=JU$3Y:(F[RN-H-C(HI
MF]A.NC_'X=G,L7(-L9KJBSB^JO\ R^/;SK6BN5A@  !XN19%8\2L=SR3)+G2
M6:Q6:!U3<[G4NY8XHV^*^O?N1$ZJO1-U4[;%BN_7%%$:U3NAU7KU%FB:ZYTI
MC?*D7B'X\,\U$K:_'=,*NNP/!&.=$RX4[EBN]Q9W<\LS5W@8[P9&J+\IR]R6
MSDFQ]C"Q%>(CAW/Z8ZN7IGL53G6U]_%3-&'\2W_5/7R=$=J <TTM1++//+)/
M/.]9)II%5SWO<N[G.<O5552:1&G%"'3.O'+\P^  "4^A_%YJUHI5TE)#=ZC+
ML+C<B5.&W>9\L38_51S.YGTR^KD]#?JYCB/9OLSA,PB9TX-?VH]\<O?YTARG
M:3%8"8C7A4?9GW3R=WF7N:0ZO8;K9AM'FF%UDDM%*]:>XVZH1&U5#5-1%?3U
M#$5R(Y$<B]%5%145%5%*>S/++V7WIM78X_5,<\+<RW,K.868NVIXO7$\TMHF
MO;!7)Q@VN^Z4:J:3\5F-T$]QHL4D98L]HX>]:*5TC6.7P3M8ZB:+F7HUW9>L
MG.S%RC&X6]EU<Z35XU/3^$Q$]&J$;2VZ\%BK68T1K%/BU='XQ,QTZ/LU+L-X
MUPUOX7M9-+:+ZKM.++-!4WK(Z6:!K*1J5K97LFCDD;(CV)\)G+NB]%3<X8"]
M1EV"Q>%Q$\&[.Z.?BY'+'V:\PQN%Q6'CA6XWSS<;:'%_H1<]6<-MV38)"^'5
MK3RI9<,/K:9[8*B>-KT=+2I,YS$145$EC55Z/;LFW.XU^S.<4X*]-N]\S7Q5
M<L=.GJGS=#8;2Y15C;,7+/SU''3S]&OKCS]+'M1N)>_Z6\.]%>]1;3]2VN=Z
MM[[5;\2=) ^66Y(BQ+<HV0/D1*=/KWL7:+OV4[\#D-O&9A-%B>%AXG7A<?D_
M9X^7D];IQN>W,'E\57XX-^8TX/%Y7VN+DY?4S7@VTDN&D6B=HH+_ $\E+E66
M5,F19)32HO:P2U;&,A@?S=4='!&SG:O<]7&)M3F5..QLS1Y%/BQU;Y[=>K1E
M;,9;5@L'$5^55XT]?)V:=>J59'4A      _B22.*-\LKV1Q1M5TDCEV:UJ=5
M557NV$1J3.CFLXF]67ZS:RY9ET,[Y;%!+[E8FU5Z-ME$KF0N;ZNU<KIE3P5Z
ME\Y!EOR#!T6_K;ZO2GX;NI16?9C\OQE=SZNZGT8^._K:!-RTX          ?
MO34]165$%)2PRU-552-AIJ>-%<^21Z\K6M:G5555V0^5513&LOL1-4Z0Z7.'
M32:FT6TCQ7"FQ,;=VP>Z&53MVWENE6B/J554Z*D?2)J_(8TH3/,RG,,77=Y-
MU/HQN^/3*]LDRZ,!A*+7+OJ]*=_PZ(;Q-2VP          4"\>.D2Z;ZTUN1
MV^G2+&M34DO="K4]&.OYD2XQ?/VKDF^:1$\"YMCLS^5X**)\JWXO5]7U<74I
MW:_+?DN,FN/)N<?7];U\?6A*2Q%     ??:[;57FYVZT4+$DK;K50T=''\J6
M=Z1L3\:G"Y7%NF:IW1QN=NB:ZHIC?+JNL%FI,=L5EQ^@3EH;%04UOHT[MHJ6
M)L3/R-/.EZ[-VNJN=\SKVO0UFU%JB*(W1&G8]<ZW8        :SU<U5Q?1G!
M;QG>5S\M';F<E!;VN1)ZZL>B]C2P(O>YZI_)3=R^BBF?EN77<??BS;WSZHY9
ME@9EF%O 6)O7-T>N>2(<VFINHV2:L9O?L\RNI[>ZWR=9.Q:J]E30)TAIH47?
M:.)FS4_&NZJJE[X# V\%9ILV]T>OGF?/*C<?CKF-O57KF^?5YH\T,",QA@
M       !<IY,C#W4>%ZCYU-%LM_NU-9Z)[N_L[;"LTBM]CG5:)\[?85;M_BN
M%>M6>:)G[TZ>Y9^P6&X-FY>YYT[/_P!6@%?I\
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M[(Y9\LQL55>3;\:>GZL=O'U(QM9F7R3!S3'E5^+'1]:>SBZW/J72ID
M     $]?)_:.-U U9?G%WI5EQS3%L=?'SM]"6[2JJ43/\5RNFZ=RM9OWD.VT
MS3Y+A/!4^5<XOY>7MW=J8;&Y9\IQ7A:O)M\?\W)V;^Q>^4\MT
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M9_)**VEQ?RG,+M7)$\&/Y>+\5X[-X7Y-E]JGEF.%][C_  20-$W@
M                           !!SRAGV.-R^_UJ_..);L3](QZ,HGMI]'S
MZ4*#BY5/)\>3B^R"K/P2N7Y^D(;MU]'QZ<=TICL/^WSZ$]\+W"GUN
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MW<C=^YK6IX%!YYCJL9C+ER=VND>C'%'YYU\9)@8P>#MVXWZ:STSQRW>:EM0
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M5TF\+VD,>BVCF,8M/3MAR*NC]U\P?TYG7*K:UTC'*G?V+4;"GL9N41M!F?\
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MIJ>"CIX*2EB9!34L;8J>!B;-8QB<K6HGJ1$//-54U3K+T#3$4QI#]SX^@
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M';K]!"=NL;X+!Q:C?7/JIXY]>B:;$8/PN+F[.ZB/75Q=VJ\HJ-;(
M                             @YY0S['&Y??ZU?G'$MV)^D8]&43VT^C
MY]*%!Q<JGD^/)Q?9!5GX)7+\_2$-VZ^CX]..Z4QV'_;Y]">^%[A3ZW
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M4W:HB(TCHAZ/]5EQ'?PO9;_G(_\ <.'Z-Y=^YI<_TBS#]]4?U67$=_"]EO\
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M61F/TK62;>DC756ZHB^WE3\1 /\ 4"?U%KTI[D]V"C]?=]&.]<T58M
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M2ROTBS#]]4?U67$=_"]EO^<C_P!P?HWEW[FD_2+,/WU1_59<1W\+V6_YR/\
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MJ(7*G>G/&JINGBG>GB0Z_A[EBK@7*9IJYIXDPL7[=^GAVZHJCGCC>Z=+M
M        !2?Y1[5CZH]0;)I5;*GGM>!0)67QC%]%]UKF(YK7>"]C3JW;U+(]
M"U]A<M\%AZL15OKXH]&/C/="J]N,Q\+?IP].ZCCGTI^$=\JVR=H,
M   #HOX/M'5T<T6L%ON-'YKEF4_].Y9S)M(R>I:G8TSM^J=A#RL5.[GYU3O*
M.VGS3Y?C:IIGQ*?%IZM\]<^K1=NS66?(<'3$QX]7C5=>Z.J/7JE*1Y(
M          "'_&!PVT^O&$>Z%B@@BU)Q*-\V-52[-\\A^%+;Y7>I_?&J_!?X
MHUSR3[,9[.6WM*_FJM_F_B^/FZD:VER.,QLZT?.4[O/_  _#S];GSJZ6IH:J
MIH:VGFI*RCE?!5TLS59)%+&O*]CVKU16JFRHI=5-451K&Y3%5,TSI.]\Y]?
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MV=JG^$*9VSQWRC'S1&ZW'!Z]\_#J7%L=@?D^!BN=]<\+JW1\>M-PB:5@
M                                "#GE#/L<;E]_K5^<<2W8GZ1CT91/
M;3Z/GTH4'%RJ>3X\G%]D%6?@E<OS](0W;KZ/CTX[I3'8?]OGT)[X7N%/K<
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M0T6T&U%.:6(M1;X.E7"WZ\DQS1SMYD&S%65WYNS<X6M.F[3EB>?S)Y$.2\
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M*IJJWS.L],K^MVXMTQ33NCB['H'!S
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MD>3/VHYO2[^G?5>U>SGR:9Q-B/$GRH^S//Z/=T*VB=H,
M       +5_)JZ2NJ;EE6LUTIE["W,=C^)N>G1T\J-DK9F_<,Y(T7N]-Z=Z%=
M;>9EI31A:>7QJO='OZH6'L+EVM5>*JY/%I]\^[KE;Z5DLH
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MU>?YW*OB7CLI;HHRVUP>76>O6=?@I+:FY77F-WA<FD=6D:?%%DD*/@
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MWV* S+'58W$5WJOK3V1R1U0OO+L%3@L/19I^K';/+/7+8Q@LT
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M ?UY7/M[9G:>,?'@;W%=C^O\>>.N/-4FTNS4X&?#6>.U/]'X<T]4^> Y,D/
M                   M?\G/H.^:IKM=\DHE2"F[:V:?1RM^'(N\=;7-W\&I
MO Q?6LOR4*XVYSC2(P=$^>OW4^^>I8NQ.4:S.+KCS4>^KW=JW4K19
M                                 (.>4,^QQN7W^M7YQQ+=B?I&/1E$
M]M/H^?2A0<7*IY/CR<7V059^"5R_/TA#=NOH^/3CNE,=A_V^?0GOA>X4^MP
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MJJ1[8O$W<7CKUZY.M4T\?;"0[98:UA<#9LVXTB*O=*H4LQ6KH?X%_L6-+O\
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M&_B7=J]44OK+<PMX^Q3>M[I]4\L2HK,<!<P-^JS<WQZXY)AK<SF"
M;(TATZN&K.I6'Z?6Y9(Y,DN#(:RJ8B*M/2,WEJY]EZ>]0L>[;QVV,',\=3@L
M-7>GZL=L\D=<L[+<%5C<119CZT]D<L]4.GFS6BW8_:+78;12QT5JLM)#0VRC
MCZ-B@IV)'&Q/F:U$//UV[5=KFNK?,ZSTRORU;IMT113NB-(ZGIG!S
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M2B;]^N_7-RN=:IG65Y6+-%FB+=$:4QQ0]HZG:
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MU6ZFI)')]N^)C7.^E37XC'8C$?.W*JNF9EL,/@</A_FJ*:>B(AFIBLH
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M761K%+&Y/6U?!>]%3HJ=4Z%IV+]N_1%=N=:9Y85??L5V*YHN1I5')+Q#M=0
M            #,<!P/*-3,LL^%X?;9;I?;U,D5/$W?DC;\>:9R(O)'&GI.<O
M<AC8S&6L):F[=G2F/SI'G9.#P=S%W8M6HUJG\ZSYG1=P^:%8YH%@5+BMH5E?
M>:SEJLLR)6<LE=6<NRKZTBC^#&WP3[97*M&YUG%S,[_A*N*/JQS1\>==V391
M;RVQX.GCGZT\\_#F;U-0VP
M
M          <E9Z2><DGN#+[)O2?^/U?Z!4D?VI^C+W1'M0W^R_TE:Z9]F71L
M4:NX
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MW4\WGGGG\PN/),CLY9;TIXZYWU<_FCFA(XT;=@
M
M                           Y*STD\Y)/<&7V3>D_\?J_T"I(_M3]&7NB
M/:AO]E_I*UTS[,NC8HU=P
M                                                        *L^-
MWA"=?FW+672VU.DOK-Y\YQ2DC3]F,1%5]PIF-ZK,G[JQ/KGPT]-%Y[#V3VF\
M'IA<1/B_5JGD_AGS<W-NW;J_VKV:\)KBL/'C?6IY_P"*//S\^_?OIW+/5D
M  "R'R<>DOU3:AWK5.Z4B26G (/-;(^1/1?=JUBMYF[ILO80<RKZE>Q2"[<Y
MEX+#TX>G?7O]&/C/=*<;$9=X7$3B*HXJ-WI3\([X79E3K5
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M[-.D?G?SLX,1E@
M
M    <E9Z2><DGN#+[)O2?^/U?Z!4D?VI^C+W1'M0W^R_TE:Z9]F71L4:NX
M
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M:+ZY%C:BO7VNW4C&)QE[$SPKM<U3YYU2;#82SAHX-JB*8\T:,L,9D
M
M
M
M                            JBXR^"Y]>^YZMZ.V=SZ]ZNJ<RP:BCW6=
M5ZOK:")OQ_&2)OPOA-]+='6-LMM5P=,-BIXOJU3R>:KW3VJ[VGV6X6N)PT<?
MUJ8[Z??'8J)5%1514V5.]"S%;/\  )><$FE'ZJ&NEAFKJ99L=P1$R.]*J>@Y
M],]/,X57N].H5JJGBUKB,[69C\CP-6GE5^+'7OGL]>B2[*9=\KQM.ODT>-/5
MN]?O=#!2:Z
M
M
M
M                              "M+BVX(J;.77+4K2"AIZ',G\]3D>(L
MVC@NSU7=T]-NJ-BJ%ZJY.C9._H_=7SW9K:V</I8Q,ZT<E7V?-//'=T;H+M'L
MI&(UOX:-*^6G[7GCFGOZ=],5;15MLK*JW7&DJK?<*&5]/74-3&Z*:&6->5\<
MD;T1S7-5-E14W0M.BN*XX5,ZQ*KJJ9HG2J-)A?'P Z4_4#HK#E=?!V=^U/F;
M=Y7+\)MNC164#/F5JNF3_"%/;9YC\IQO@X\FWQ=?UOAU+>V.R[Y-@_"3Y5SC
MZOJ_'K3G(@EH
M
M
M
M                                 C=K/PIZ/ZY5<-VRNTUMJR.+D23)
M[')'25L\;.B1SJ^.6.5-DV17L5R)T:Y#>Y5M'C,NC@VYUIYJN..K=IVM'FFS
MV$S&>%<C2KGIXIZ]^J0]#14EMHJ2W4$$=+0T$,=-1TL:;,CBB:C&,:GJ1$V-
M)75-<S,[Y;JFF*8B(W0^HXN0
M
M
M
M
M
M
M
M
M
M
M
M
5                        ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k1820.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amicustherapeutics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k1820.htm">form8-k1820.htm</File>
    <File>exhibit99120.htm</File>
    <File>fold-20200108.xsd</File>
    <File>fold-20200108_cal.xml</File>
    <File>fold-20200108_def.xml</File>
    <File>fold-20200108_lab.xml</File>
    <File>fold-20200108_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>form8-k1820_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fold-20200108.xsd" xlink:type="simple"/>
    <context id="D2020Q1F81920">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178879</identifier>
        </entity>
        <period>
            <startDate>2020-01-09</startDate>
            <endDate>2020-01-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q1F81920"
      id="Fact-39F0D1B9FA3656AB82ABEA2BB54AC77A-wk-Fact-39F0D1B9FA3656AB82ABEA2BB54AC77A">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q1F81920"
      id="Fact-9D9CBBC7F8B5527895286921A980325E-wk-Fact-9D9CBBC7F8B5527895286921A980325E">0001178879</dei:EntityCentralIndexKey>
    <dei:WrittenCommunications
      contextRef="D2020Q1F81920"
      id="Fact-DD7CC582EA82571ABEFD10A8483E1C47-wk-Fact-DD7CC582EA82571ABEFD10A8483E1C47">false</dei:WrittenCommunications>
    <dei:DocumentType
      contextRef="D2020Q1F81920"
      id="d2561432e76-wk-Fact-70AF32C9AE8F591683EAABE3EAF4B39D">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q1F81920"
      id="d2561432e97-wk-Fact-ED705A4B71145D6BA43E3DD1E8C921CF">2020-01-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q1F81920"
      id="d2561432e102-wk-Fact-C4C1D41D7FE95C1B96150FF29DE648C7">AMICUS THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q1F81920"
      id="d2561432e114-wk-Fact-76AD74269FE2569685347FEB38645DFA">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q1F81920"
      id="d2561432e151-wk-Fact-92994F666DDE508EAA3D6A19365E3162">001-33497</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q1F81920"
      id="d2561432e161-wk-Fact-3A088C8F63635F5EA41B8C5389F1141B">71-0869350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q1F81920"
      id="d2561432e205-wk-Fact-B5C474C84B35575488B2D287E5C5D2F9">1 Cedar Brook Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q1F81920"
      id="d2561432e209-wk-Fact-F8066B6AAB9B584C9FCABDC4D7455F35">Cranbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q1F81920"
      id="d2561432e213-wk-Fact-C9467773142950ACB7C5E5E3A3450C19">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q1F81920"
      id="d2561432e217-wk-Fact-11B12A4FE62A5AF6952C9A440F189368">08512</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q1F81920"
      id="d2561432e227-wk-Fact-FCD11A83243A550DBCAC5637EFEC22E5">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q1F81920"
      id="d2561432e231-wk-Fact-2461D98A867F5701B747952166DFE458">662-2000</dei:LocalPhoneNumber>
    <dei:SolicitingMaterial
      contextRef="D2020Q1F81920"
      id="d2561432e263-wk-Fact-78CA76BCA0995796993478AC28B71F8B">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q1F81920"
      id="d2561432e270-wk-Fact-3D1C11778A125FAF9B430C81BE22375F">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q1F81920"
      id="d2561432e277-wk-Fact-210DC4E11E0D505FBD1574CF98F50B92">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q1F81920"
      id="d2561432e317-wk-Fact-219FFDE2D4F35DF5B58F0BD2D07F2D23">Common Stock Par Value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q1F81920"
      id="d2561432e322-wk-Fact-52B21E5F456554168B36240C10137901">FOLD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q1F81920"
      id="d2561432e327-wk-Fact-920F42AADC6E5247A2D7476D699C18CF">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q1F81920"
      id="d2561432e332-wk-Fact-F44E3590AD4C59CAB5710C333D01AC54">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6630026256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Jan. 09, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  09,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMICUS THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">71-0869350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Cedar Brook Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranbury<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">662-2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock Par Value $0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FOLD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k1820.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "fold-20200108_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fold-20200108_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k1820.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fold-20200108_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fold-20200108_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "fold-20200108.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fold",
   "nsuri": "http://www.amicustherapeutics.com/20200108",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8-k1820.htm",
      "contextRef": "D2020Q1F81920",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.amicustherapeutics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8-k1820.htm",
      "contextRef": "D2020Q1F81920",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( '0X*5 ?(\\#P    !,"   +    7W)E;',O+G)E;'.MDD^+
MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V
M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F'
M.>RGGD7E2B.5^S3%":4A+<TXP)6E/S/WJVR;A5ND9T*YKCM+1[873T$7LF<;
M!I99-G\LCNVW<+ZT+/0:S>,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C
M-R."?S]PN -02P,$%     @ =#@I4"?HAPZ"    L0   !    !D;V-0<F]P
M<R]A<' N>&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(?
MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M/_QNPJXW]F#_L?%54+;PZR[D%U!+ P04    " !T."E0F5R<(Q &  "<)P
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MQ&IZ8/:J8-D_JT./^N(74$L#!!0    ( '0X*5"ZH3F*UP$  #(&   -
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ =#@I4$TV)[#N    *P(  !$
M             ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M=#@I4)E<G",0!@  G"<  !,              ( !M@(  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " !T."E04[A14: "  "8"P  &
M    @ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M=#@I4*B^*:U- @  V@4  !0              ( !S0L  'AL+W-H87)E9%-T
M<FEN9W,N>&UL4$L! A0#%     @ =#@I4+JA.8K7 0  ,@8   T
M     ( !3 X  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !T."E0+6VE:#H!
M   G @  #P              @ %.$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ =#@I4/_ )@B]    A0(  !H              ( !M1$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ =#@I4 N/V ,A 0
M5P0  !,              ( !JA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      H "@"  @  _!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001178879-20-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178879-20-000004-xbrl.zip
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MWOC&.[4>VQ/8(*=TQN"V*4!SJ?G9D&WE%48SK[I8(O%FE+ ,'#%U_6WJ'H:
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M]86P$RN,99\6.YF_L945AMJ&M[*L-M31P3]02P,$%     @ =#@I4-QP\;U
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MHJIE[Z/?I7 F>2/#)++>_L*]VO^K.HM!YT#ED >Y*;WY![/!)U!+ P04
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MEPM:#YH#3]F&Y.1F'7?^ E!+ P04    " !T."E0V690H(H+   :9@  %0
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M4(@TJ@LP[+1@#QW:V?7ZB&BI/^NJ<.K#XBR;3<?38CJ__&T4&F\ZF@V5)UY
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MV\:2?C[Y%;/,GI1=99*X7VA9IW!-E#B2CB1O4OL& D,1QR#  * D[J_?G@%
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M'4TSFH-8%)BV C[512CRCLB8YB6JE_X0@:!S)4LR.?U5J42 4PCB@9+CF[B
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M,#(P,#$P.%]C86PN>&UL4$L! A0#%     @ =#@I4*%GGA.G 0  T@4  !4
M             ( !*1H  &9O;&0M,C R,# Q,#A?9&5F+GAM;%!+ 0(4 Q0
M   ( '0X*5#99E"@B@L  !IF   5              "  0,<  !F;VQD+3(P
M,C P,3 X7VQA8BYX;6Q02P$"% ,4    " !T."E0GOZ[>)X&   <-0  %0
M            @ ' )P  9F]L9"TR,#(P,#$P.%]P<F4N>&UL4$L! A0#%
M  @ =#@I4+ A&+:5%P  :I@   \              ( !D2X  &9O<FTX+6LQ
=.#(P+FAT;5!+!08     !P ' ,8!  !31@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
